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Abstract
The host inflammatory response may be involved in the pathogenesis o f severe malaria. 
High plasma levels of pro-inflammatory cytokines, notably tumour necrosis factor (TNT), 
are found in African children with cerebral malaria. Experimental evidence also implicates 
TNF in the pathogenic process o f severe malarial anaemia. We have examined the 
association o f polymorphisms in the TNF gene promoter region with severe malaria in a 
large case-control study o f Gambian children. Cerebral malaria, but not severe malarial 
anaemia, was found to be associated with the TNF.308 A promoter allele (TNF2). 
Homozygotes for this allele had a relative risk o f 7 for death or severe neurological 
sequelae due to cerebral malaria and this association was independent o f variation in the 
neighbouring HLA class I and class 11 alleles. In the same population severe malarial 
anaemia was associated with the TNF.238 A promoter allele with an odds ratio o f 2.5 after 
stratification for HLA type. These data suggest that regulatory polymorphisms o f cytokine 
genes can affect the outcome of severe infection and that severe malarial anaemia and 
cerebral malaria are influenced by separate genetic factors situated in the neighbourhood of 
the TNF gene.
TNF is an endogenous pyrogen and a critical mediator of malaria fever. However, high 
plasma levels of TNF are sometimes found in afebrile African children with Plasmodium 
falciparum  parasitaemia, A proposed mechanism for this apparent clinical tolerance is that 
soluble forms of TNF receptors (sTNF-R55 and sTNF-R75), that are known to inhibit TNF 
bioactivity in viiro, modulate the pyrogenic effect of TNF in vivo. We have measured the 
plasma levels of TNF, sTNF-R55 and sTNF-R75 in relation to episodes of malaria fever 
detected in a cross-sectional study o f rural Gambian children during the malaria 
transmission season. TNF levels were significantly higher in children who were both 
parasitaemic and febrile, compared to those who were parasitaemic but afebrile and those 
who had no detectable parasitaemia. In contrast, soluble TNF receptor levels did not differ 
between these clinical groups and, in a logistic regression model that included level of 
parasitaemia, TNF but not soluble TNF receptor levels was associated with the presence of 
fever. These data support the role of TNF in malaria fever but suggest that soluble TNF 
receptors are not a major factor in môdulaftflgÿhe fever.
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Sequestration o f parasitised erythrocytes in post-capillaiy venules in critical areas of the 
brain is believed to be a critical step in the pathogenesis o f cerebral malaria. High levels of 
pro-inflammatory cytokine production may exacerbate sequestration by up-regulating the 
expression of the specific endothelial receptors to which parasitised erythrocytes bind. One 
o f the best characterised of these receptors is intercellular adhesion molecule-1 (ICAM-1). 
An indirect measure of ICAM-1 expression may be provided by the amount o f circulating 
ICAM-1 (cICAM-1) in the plasma. In a case-control study o f severe malaria, we have 
found that the plasma levels o f cICAM-1 to be higher in Gambian children with acute 
malaria than in those with non-malarial illnesses. cICAM-1 levels correlated with levels of 
TNF, interleukin-1 alpha (IL-1) and interferon-gamma, supporting the view that these 
cytokines are responsible for a general up-regulation of ICAM-1 expression in malaria. 
However, in contrast to the finding for TNF and IL-1, cICAM-1 levels were unrelated to 
malaria disease severity. The tissue distribution o f ICAM-1 expression, rather than the total 
level of expression may be the more important determinant of whether an individual child 
develops cerebral malaria.
The host acute intlammatoiy response to malaria parasitaemia may provide a useful 
surrogate measure of disease activity. Two such potential measures o f malarial morbidity 
are (i) elevated plasma C-reactive protein (CRP) plus detectable parasitaemia, as an 
indicator of the malaria-induced acute-phase response; and (ii) reduced plasma haptoglobin, 
which in children resident in malaria endemic areas of sub-Saharan Africa indicates malaria- 
induced intravascLilar haemolysis. We have compared these indices with the traditional 
malariometric indices in a cross-sectional sui*vey that was undertaken to determine the 
impact of bed net usage in 1505 rural Gambian children. At the end of the malaria 
transmission season the proportion of children who had parasitaemia plus elevated CRP 
was significantly lower than in those who had slept under insecticide-treated bed nets 
compared to those who did not use a bed net. The proportion with a low haptoglobin 
differed similarly. We conclude that these indices could be useful for the assessment of the 
impact of intervention programmes on malarial morbidity in mral African communities.
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General Introduction
Plasmodium falciparum malaria remains endemic in many areas of sub-Saharan Africa. 
Young children bear the brunt o f morbidity and mortality; older children and adults have 
acquired clinical immunity. The best estimates suggest that around 200 million clinical 
episodes of falciparum malaria occur each year in African children under the age of five 
years. The majority o f these are episodes of mild malaria; parasitaemia resulting in a self- 
limiting febrile illness. Life-threatening disease develops in only a minority of instances 
(approximately 1-2%), but causes up to 2 million childhood deaths in Africa annually 
(Greenwood ei al., 1991). An improved understanding of the pathogenesis o f malaria and 
o f the nature o f clinical immunity is essential if better methods o f reducing the huge burden 
o f malaria morbidity and mortality are to be developed (Marsh et a l,  1992).
Severe malaria in African children
In children living in malaria endemic areas of sub-Saharan Africa the most important severe 
complications o ïP. falciparum infection are cerebral malaria (coma, often in association 
with seizures) and severe malarial anaemia (usually defined as haemoglobin <5g/dl 
associated with asexual P. falciparum parasitaemia) (Warrell e( a i,  1990). Although these 
conditions can be considered as clinically distinct, occurring at peak incidence in difterent 
age groups, children can present with both conditions simultaneously (Brewster et a i,
1990). More recently the importance of additional indicators o f severe disease, such as 
respiratoiy distress associated with acidosis, hypoglycaemia, and poor peripheral perfusion, 
has been highlighted (Marsh et a i, 1995; English et a i, 1996, 1997). Hepatic failure, renal 
failure and pulmonary oedema, features of severe malaria that are common in non-immune 
adults, are rarely seen in African children (Warrell et a i, 1990).
The mortality from malaria in African children is high despite effective anti-malarial therapy. 
A hospital-based study o f Gambian children with cerebral malaria documented a fatality rate 
o f 16%, with a ftirther 9% affected by major neurological sequelae such as hemiplegia and 
cortical blindness (Brewster et a i, 1990). Given the low level o f health care provision 
throughout much of rural Africa, it is likely that many children die before reaching hospital. 
In The Gambia the overall malaria mortality rate in children under the age o f 5 years is 
estimated at 6.1 per 1000 (Greenwood & Pickering, 1993). The widespread emergence of 
chloroquine-resistant P. falciparum may increase this rate still further (Marsh, 1998).
8
Prospects for malaria control
Global malaria eradication is now regarded as unfeasible and the current World Health 
Organisation emphasis has shifted to malaria control. Community-based measures that 
reduce mosquito contact, such as insecticide-impregnated bed net and curtain use, have 
been shown to reduce malarial morbidity and mortality, but the sustainability o f this form of 
intervention is unclear (D'Alessandro et a l,  1995a; Binka et ah, 1996; Nevill et a i,  1996). 
Chemoprophylaxis may be o f some value in particular circumstances, such as pregnancy, 
but is unlikely to be a useful long-term preventative strategy for the vast majority o f 
susceptible children (Greenwood, 1997). With regard to vaccine development, the only 
malaria vaccine so far tested in large field studies has been the synthetic polypeptide vaccine 
SPf66. Although a trial in Tanzania did indicate that SPf66 provided some protection 
against clinical malaria (Alonso et a i,  1994), a large prospective study in Gambian infants 
failed to show any significant degree of protection (D’Alessandro et a i, 1995b). Field trc^ls 
of two other malaria vaccines are currently underway, but no major vaccine candidates is 
likely to be in extensive use in near future. Insecticide-impregnated bed nets probably offer 
the best option for malaria control at present and renewed efforts should be directed 
towards improving the sustainability o f this intervention (D’Alessandro, 1997; Greenwood, 
1997).
Why do only a minority o f children develop severe disease?
African children resident in malaria endemic areas are repeatedly infected with Plasmodium 
falciparum, but in only a minority o f instances does infection progress to severe disease 
(Fig. 1). It is likely that many interacting factors, including vector and parasite factors, 
socio-economic, behavioural and other host factors, contribute to the overall risk o f disease 
progression (Table 1). An improved understanding of how these factors determine the 
clinical consequence o f P. falciparum infection may help in the development of better or 
novel approaches for treatment or control (Greenwood et al., 1991; Marsh et al., 1992).
Fig. 1. The possible outcome of inoculation with malaria sporozoites. The numbers indicate 
how many African children are likely to fall into each category for every child who dies 
from malaria. The proportion o f infected children progressing to symptomatic disease will 
vary, being low in areas of very high endemicity. Modified with permission from 
Greenwood et a!., 1991.
400 infectious bites 
200 infected children 
100 mild malaria cases
r
2 severe malaria cases
r
1 death
Table I. Factors which may influence the clinical outcome o f malaria infection.
Vector: Multiple factors affecting cumulative sporozoite dose.
Parasite: Inter-dependent factors; growth, cytoadherence, immune evasion and
drug resistance.
Host: Level o f acquired immunity, nutritional status, genetic susceptibility.
Availability of health care, community usage of anti-malarials, local 
mosquito avoidance practices.
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H(xst genetic factors affecting disease susceptibility
The role of host genetic factors in affecting susceptibility to severe malaria was first 
illustrated by epidemiological findings o f a high prevalence of red blood cell abnormalities, 
such as sickle cell trait, thalassaemia and glucose-6-phosphate dehydrogenase (G6PD) 
deficiency, in areas of high malaria endemicity (Allison, 1954, 1960; Willcox et a i,  1983; 
Flint et al., 1986). More recently the degree of protection conferred by these 
polymorphisms has been quantified (Hill et a i,  1991a; Ruwende et a i,  1995; Yates et a i, 
1995). Intriguingly, a recent study in Vanuatu has indicated that alpha-thalassaemia may 
protect against severe falciparum malaria by increasing susceptibility to P. v/vax infection in 
young childhood and affording a degree o f cross-species protection (Williams et at., 1996). 
This situation does not exist in the West Africa population, where absence of the Duffy 
blood group antigen on the red cell surface prevents invasion by P.vivax (Miller et at,
1976).
The role of immune response genes, particularly human leucocyte antigen (HLA) class I and 
class II alleles, in determining the clinical consequence of infection has also been 
investigated. A large case-control study o f severe malaria in Gambian children 
demonstrated an association o f the HLA class I allele, HLA-B53, with protection against 
cerebral malaria and severe malarial anaemia, and o f the HLA class II allele, HLA- 
DRBl* 1302, with protection against severe malarial anaemia (Hill et a i, 1991a).
Fhe host inflammatory response in the pathogenesis o f severe malaria 
In addition to HLA-class I and class II alleles, many other host genes are involved in the 
immune response to infection and the role played by the host cytokine response in the 
pathogenesis of malaria has been a subject of considerable interest. Attention has focused 
on the pro-inflammatoi-y cytokines interleukin-1 (IL-1), IL-6 and, in particular, tumour 
necrosis factor (TNF). TNF is released by host monocytic cells in response to products of 
ruptured malaria schizonts (Kwiatkowski, 1989). TNF stimulates various processes that can 
inhibit the growth of F. falciparum, including fever, phagocytosis, and the release of nitric 
oxide and reactive oxygen intermediates (Clark et a i, 1987; Kwiatkowski, 1989; Taylor- 
Robinson et a i, 1993). Several studies have demonstrated an association between elevated 
plasma concentrations o f TNF and malaria disease severity. Therefore, although it is
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recognised that TNF and other pro-inflammatory cytokines are critical mediators of host 
defence, it has been proposed that excessive generation of TNF may contribute to the 
development o f severe disease, particularly cerebral malaria (Grau et a!., 1989; Kern et a!., 
1989; Kwiatkowski et a!., 1990).
TNF may be involved in the development o f cerebral malaria by up-regulating the 
expression o f endothelial adhesion molecules, such as intercellular adhesion molecule-1 
(ICAM-1), vascular cell adhesion molecule-1 and E-selectin, which mediate the 
cytoadherence o f infected erythrocytes to cerebral blood vessels (Berendt et a i ,  1989; 
Ockenhouse et a i,  1992a). TNF may contribute to the hypoglycaemia and lactic acidosis 
commonly associated with cerebral malaria (Krishna el a i,  1994). It has also been proposed 
that TNF production at sites of parasitised eiythrocyte sequestration may induce the release 
of nitric oxide by vascular endothelium, thus perturbing neurotransmission (Clark et a i, 
1992).
With regard to severe malarial anaemia, the pathogenic process is multifactorial and only 
partly explained by direct destruction of erythrocytes (Weatherall, 1993). Studies in 
Gambian children have indicated that the suppression o f erythropoiesis may be of 
importance (Abdalla el a i ,  1980). Several lines o f  experimental evidence suggest that 
erythropoiesis can be severely dismpted by TNF. (Clark & Chuadhri, 1988; Johnson el al., 
1989; Taverne el a i ,  1994). It may be that chronic low-grade production of TNF 
contributes to the pathogenesis o f malarial anaemia but there are little clinical data available 
to support this theory.
The series of papers presented in this thesis relate to the further investigation o f various 
aspects o f the role of TNF and the host acute inflammatory response in the pathogenesis of 
falciparum malaria in African children. Four related areas of work are described, over the 
following five chapters, as summarised below:
TNF promoter polymorphisms and severe malaria (Chapters H and III)
We have applied a genetic approach to the investigation of the role of TNF in severe malaria in 
Gambian children. The gene for TNF resides within the class III region of the major
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histocompatability complex, approximately 250kb centromeric of HLA-B and 900kb telomeric 
ofHLA-DR. The first polymorphism to be described in the TNF promoter region, at -308 
nucleotides relative to the transcription start site, was identified in a Northern European 
population by Wilson eta/. (1992). A second polymorphism, at -238 nucleotides in the TNF 
promoter, was identified in an Italian population (D ’Alfonso & Richiardi, 1994). As described 
above, in a large case-control study in Gambian children undertaken between 1988 and 
1990, Hill el a!. (1991a) have demonstrated the association of severe malaria with FFLA class 1 
and class II alleles. Using this library o f clinical samples we have now examined the 
association between clinical condition and TNF promoter polymorphisms.
Inhibitory INF binding proteins in malaria fever (Chapter IV)
TNF is an endogenous pyrogen, but liigh plasma levels have been found in parasitaemic children 
who are afebrile (Peyron et at,, 1990; Mshana et ai, 1991). We wished to explore the 
possibility that circulating forms of the two cell-suiface l eceptors for TNF ( sTNF-RI and 
STNF-R2), which have been demonstrated to inhibit the bioactivity of TNF in vitro (Seckinger 
et a i, 1988; Engelmann et ai., 1990), modulate the pyrogenic activity of TNF in ww.We 
undertook a suivey of rural Gambian children during the malaria t ransmission season and 
measured the plasma levels of TNF, sTNF-Rl and sTNF-R2 in order to determine their 
respective associations with malaria fever episodes.
IJp-reguiation o f ICAM-1 in cerebral malaria (Chapter V)
An important factor in the pathogenesis o f cerebral malaria may be TNF-mediated up- 
regulation of endothelial receptors for parasitised erythrocytes as this may lead to increased 
sequestration at critical sites in the brain. This is consistent with the pathogenic process 
seen in one murine model of malaria, where TNF-induced over-expression of ICAM-1, a 
well-characterised endothelial receptor for parasitised erythrocytes (Berendt et at., 1989, 
1992), underlies the obseiwed neuro-pathological changes (Grau et a i, 1987, 1991). The 
plasma level o f the shed form o f ICAM-1 (cICAM-1) is a potentially useful surrogate 
indicator of tissue ICAM-1 expression. We measured clCAM-1 in children recruited to the 
Gambian case-control study of severe malaria in order to determine if cerebral malaria was 
associated with increased generalised expression o f ICAM-1 compared to children with 
uncomplicated malarial illness.
The inflammatory response as a marker o f disease in the community (Chapter VI)
As discussed previously, in African children living in malaria endemic regions, malarial 
morbidity is not indicated solely by the presence of parasitaemia (Marsh, 1992). An 
awareness of the role of the host inflammatoiy response in the malaria disease process has 
led to the suggestion that stable biochemical markers of the acute-phase response may be 
developed as surrogate indicators of disease activity for use in community surveys 
(Rougemont et a i, 1988; Sisay et al., 1992; Hurt et a l, 1994). The aim o f this study was to 
investigate the use o f the acute phase proteins C-reactive protein (CRP), which is generated 
in response to pro-inflammatory cytokines, and haptoglobin, which indicates intra-vascular 
haemolysis, as surrogate markers o f malaria morbidity. To accomplish this, we surveyed 
1505 Gambian children at the end of the malaria transmission season and assessed the 
impact a community- based malaria intervention programme (insecticide-impregnated bed 
net usage) on conventional malariometric indices and on the plasma levels of CRP and 
haptoglobin.
I l
Variation in the TNF promoter region associated 
with susceptibility to cerebral malaria
^McGuire, W., A.V.S., ^Allsopp, C.E.M., '’Greenwood, B.M. &
'Kwiatkowski, D. (1994). Nature, 371, 508-511.
^Department o f  Paediatrics and ^Nuffield Department o f  Medicitie, 
Institute o f  Molecular Medicine, John Radcliffe Hospital, Oxford, UK: 
'M edical Research Council Laboratories, b'ajara. The Gambia.
■Summa:y
TNF is believed to have an important role in the pathogenesis o f severe infectious disease 
and fatal cerebral malaria is associated with high circulating levels o f this cytokine. In a 
large case-control study of malaria in Gambian children we have found that homozygotes 
for the TNF.308 A allele, a variant o f the TNF gene promoter region, have a relative risk of 
7 for death or severe neurological sequelae due to cerebral malaria. Although the TNF .308 A 
allele is in linkage disequilibrium with several neighbouring HLA alleles, we have shown 
that this disease association is independent of HLA class I and class II variation. These data 
suggest that regulatory polymorphisms of cytokine genes can affect the outcome o f severe 
infection. The maintenance o f the TNF.308 A allele at a gene frequency of 0.16 in The 
Gambia implies that the increased risk o f cerebral malaria in homozygotes is 
counterbalanced by some biological advantage.
Introduction
It is not known why cerebral malaria occurs in only a small proportion o f individuals 
infected with Plasmodium faicipanini. A critical factor may be the amount o f TNF that is 
produced when malaria schizonts mpture (Kwiatkowski, 1989). Clinical studies have 
demonstrated an association between TNF levels and disease severity (Grau ei al., 1989; 
Kern e( a!., 1989; Kwiatkowski et a i ,  1990) and experimental studies have revealed several 
ways in which excessive TNF production could promote cerebral malaria (Clark et a i ,
1987; Grau et at., 1987). A prominent feature of this condition is parasite sequestration 
within cerebral blood vessels, and TNF is known to up-regulate the expression o f host 
adhesion molecules that mediate the binding o f parasites to vascular endothelium (Berendt 
et a!., 1989). It has also been proposed that local high concentrations o f TNF may stimulate 
cerebral endothelium to overproduce nitric oxide, thus causing coma by interfering with 
neurotransmission (Clark et a!., 1992).
These observations raise the possibility that cerebral malaria is related to the genetic 
propensity of the host to produce TNF. The gene for TNF resides within the class III region 
o f the major histocompatibility complex (ÎVIHC) and several studies have shown that
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individual differences in TNF production can be linked to HLA type and other polymorphic 
markers in this region (Molvig ei a!., 1988; Jacob et at., 1990; Pociot et at., 1993). This 
suggests that TNF responsiveness is controlled by variable genetic elements within the 
MHC but the precise location o f these elements has yet to be identified. A polymorphism 
that may directly affect the regulation o f TNF is located at -308 nucleotides relative to the 
transcriptional start site o f the gene (Wilson et a i ,  1992, 1993). There are two allelic forms, 
referred to as TNF.?o8 G (originally termed T N Fl) and TNF.308 A (originally termed TNF2) 
that are identical apart from a single base transition (G to A) at position -308 o f TNF. 
Studies of the TNF promoter linked to a chloramphenicol acetyl transferase reporter gene 
have shown that the TNF .308 A allele is associated with higher constitutive and inducible 
levels of transcription than the TNF .308 G allele (Wilson et at., 1994). Because o f the 
possible functional significance o f this polymorphism, we have investigated its association 
with cerebral malaria.
Subjects and Methods
Our analysis was based on a large case-control study of severe malaria in Gambian children. 
The details of this study have been described previously (Hill et at., 1991a). Children aged 1 
to 10 years were enrolled, with the permission of a parent or guardian, at the Royal Victoria 
Hospital, Banjul, the MRC Clinic, Fajar a, and neighbouring health centres during the 1988- 
1990 rainy seasons. Cerebral malaria was defined as a Blantyre coma score <3 (persisting 
for >30 minutes after effective treatment o f hypoglycaemia or convulsions) or repeated 
prolonged seizures (>30 minutes) in a child with P. falciparum  parasitaemia and no other 
apparent cause o f fits or coma. A further group of children with severe malarial anaemia but 
without cerebral complications was also investigated. Severe malarial anaemia was defined 
as haemoglobin <5g/dl in association with asexual P. falciparum  parasitaemia of >2500/ul.
The severe malaria group was matched to the two control groups for area o f residence 
around Banjul. Our primary' control group was composed of children who presented to 
clinic with a variety o f mild illnesses other than malaria; all were free of parasitaemia and 
well enough to be treated as outpatients. These 'mild non-malaria' controls were used to 
estimate background allele frequencies and relative risks. Around 65% had upper
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respiratoiy tract infections, mild chest infections, or otitis media; 25% had mild 
gastroenteritis or other abdominal complaints and 10% had other minor illnesses. The 
second group were children with an uncomplicated febrile illness with asexual Plasmodium  
falciparum  parasitaemia and no other evident cause of fever. These 'mild malaria' patients 
were used to test the hypothesis that the TNF .308 A allele predisposes to cerebral malaria 
rather than malaria illness in general.
Typing o f  (he TNF gene
DNA was extracted by standard methods from venous blood samples. To type the 
polymorphism, polymerase chain reaction (PCR) was used to amplify a 519 base pair 
fragment of the TNF promoter region, spanning -502 to +17 nucleotides relative to the 
transcriptional start site as defined by Nedospasov et a i  (1986). Approximately lOOng of 
genomic DNA extracted from venous blood was added to 25ul reaction mixture containing 
0.1 uM of each primer (5'-CAAACACAGGCCTCAGGACTC-3' and 5'- 
AGGGAGCGTCTGCTGGCTG-3') with lOOuM of each dNTP (Boehringer Mannheim, 
Germany), 67mM Tris-HCl, 16mM (NH4)2S0 4 , 2mM MgCl2 , and 0.01% Tween-20. After 
heating at 95"C for 10 minutes, 1.5U of Taq DNA polymerase (Bioline, UK) was added, 
followed by 35 cycles at 95"C for 1 minute, bO^ ’C for 1 minute, 72"C for 1 minute, then a 
final 10 minutes at 72“C. Template-free controls were included in each experiment. The 
PCR product was denatured with 0.4M NaOH, dotted onto nylon membrane via a vacuum 
manifold, and fixed for 1 minute in UV light. Allele-specific oligonucleotides (5'- 
AGGGGCATGGGGACGGG-3' for the TNF .308 G allele and 5'- 
AGGGGCATGAGGACGGG-3' for the TNF .308 A allele) were end-labeled with 
digoxigenin-ddUTP (Boehringer Mannheim, Germany) and hybridised to the membranes in 
3M tétraméthylammonium chloride (TMAC) solution at 55‘"C for 1 hour. Excess probe was 
removed by washing in 2x SSPE/0.1% SDS at room temperature and subsequently in 3M 
TMAC at 58"C. The membranes were treated with anti-digoxigenin Fab fragments and, 
after washing to remove excess antibody, they were incubated with Lumigen PPD ddUTP 
(Boehringer Mannheim, Germany) and exposed to X-ray film for 15-30 minutes. Two 
independent observers scored allele type. The accuracy of this method was confirmed by 
DNA sequencing of the PCR product, as described below, in three TNF .308 G 
homozygotes, three TNF .308 A homozygotes, and four heterozygotes.
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To explore the possibility that the TNF .308 A allele might be linked to some other regulatory 
polymorphism, we sequenced between -502 and +250 nucleotides relative to the 
transcriptional start site o f the TNF gene in 20 individuals who were typed by PCR as 
TNF2 homozygotes. The PCR product described above was purified and directly 
sequenced using the cycle sequencing technique (US Biochemical, USA) with the internal 
oligonucleotide 5'-TCCTGCATCCTGTCTGGAAG-3' in a labeling reaction which omitted 
dCTP. In addition, we used the primers 5'-CCGCTGGTTGAATGATTCT-3’ and 5'- 
T GAT C C T G A AG AGG AGAGA- 3 ' to amplify a second overlapping PCR product which 
was analysed over the region -73 to +250 using the internal oligonucleotide 5'- 
CCTCCTCTCGCCCCAGGG-3' (omitting dGTP in the labelling reaction).
HLA typing
Class I types were analysed by serological testing o f fresh or cryopreserved lymphocytes, 
using 180 well-characterised antisera in a standard microlymphocytotoxicity assay. The 
apparent homozygote frequencies given in Table 5 tend to be overestimates of the true 
homozygote rate because of the presence o f serologically undetected alleles, particularly the 
values for FILA-C. HLA-B53 antigen types were either determined serologically or by 
allele-group-specific PCR amplification and oligonucleotide hybridisation as described by 
Allsopp et at. (1991). Class II types were determined by restriction fragment length 
polymorphisms using Taq\ digestion with DRB- and DQB- specific probes, supplemented 
by PCR-oligonucleotide analysis as described by Hill et a i  (1992). The full range o f HLA 
types identified is reported by Hill et at. (1991b).
Statistical at lalysis
Clinical groups were compared by test, using stratified Mantel-Haenszel weighted 
analysis to correct for the possible confounding effect o f ethnic heterogeneity and to 
examine for interactions with neighbouring HLA alleles.
Hthical approval
The study was approved by the Gambian Government / Medical Research Council Joint 
Ethical Committee.
Results
Three hundred and seventy-six cases o f cerebral malaria were compared with two groups of 
controls recruited at the same clinics, frequency matched for area of residence (Table 2).
The cerebral malaria sample included 45 children who also had severe malarial anaemia. 72 
o f the children with cerebral malaria died. A further 27 had disabling neurological sequelae 
when discharged from the ward. The typical clinical features have been previously described 
(Brewster et at., 1990). Deaths and severe neurological sequelae were combined in this 
analysis because o f the previous finding that both o f these adverse outcomes tend to be 
associated with high TNF levels (Kwiatkowski et al., 1990).
The mean age o f the cerebral malaria cases was 3.9 years; mild malaria controls, 3.9 years; 
mild non-malaria controls, 2.9 years; severe malarial anaemia cases, 2.3 years. The ethnic 
composition of the study population was Mandinka (45%), Jola (15%), Wolof (14%), Fula 
( 1 1 %), and other groups (15%).
Association o f  the TNF.^os A allele with pre.^enting clinical condition 
The gene frequency o f the TNF-30S A allele in this population was 0.16, and its distribution 
in the control groups was consistent with Flardy-Weinberg equilibrium. Among cases of 
cerebral malaria there was a significantly higher frequency o f TNF .308 A homozygotes than 
in non-malaria controls (A^=6.5, P=^0.0\) or mild malaria controls (A^=4.1, P-0.04). The 
frequency of TNF .308 A homozygotes was even higher in those cases o f cerebral malaria 
who died or developed gross neurological sequelae (Table 2), This was analysed by Fisher 
exact test, because of the small number of homozygotes involved, and found to be 
significantly different from non-malaria controls (P=0 .0 0 l) or mild malaria controls 
(/^=0.005). Cases o f severe malarial anaemia without cerebral complications had a similar 
frequency of TNF .308 A homozygotes to the two control groups. A detailed breakdown of 
homozygote frequencies by ethnic group is given in Table 3. Using the mild non-malaria 
controls to represent the background population and stratifying for ethnic group, we 
estimate that TNF .308 A homozygotes have a relative risk of 4.0 for cerebral malaria (95% 
confidence interval (Cl), 1.2-13.8; =5.4, P=0.02, Mantel-Haenszel test) and o f 7.7 for
death or sequelae due to cerebral malaria (95% Cl, 1.9-30.0; A^= 10.2, /^=0.001)
2 0
T a b le  2. T N F .308 A  allele and hom ozygote frequencies by clinical category.
Sample size
TNF-308 a
homozygotes
%
TNF.308 A 
heterozygotes 
%
Mild non-malaria 325 1,2 29.8
Mild malaria 332 26.8
Severe malaria anaemia 1 1 31.5
Cerebral malaria 
A l cases
Deaths and sequelae
376
99
4,5
8,1
26.6
25.3
Table 3. TNF .308 A homozygote frequencies stratified by ethnic group (sample size in 
parentheses).
Mandinka Jola Wolof Fula Other
Mild non-malaria controls 2 .0%
(151)
0 .0%
(41)
0 .0%
(38)
0 .0%
(35)
1.7%
(60)
Cerebral malaria 
A l cases 3.9%
(153)
8 . 1%
(62)
5.1%
(59)
2.3%
(44)
3.4%
(58)
Deaths and sequelae 7.0%
(43)
15.0%
(20)
0 .0%
(13)
9.1%
( 1 1 )
8.3%
( 12)
21
Significant associations between the TNF .308 A allele and HLA phenotypes that are present 
at >2% frequency in this population are shown in Table 4. Because of the multiple 
comparisons made, P  values were corrected by multiplying the number o f concurrent tests 
performed, namely 3 |^class I types and 18 class II types. TNF-308 A was not associated with 
any HLA-A type. HÛA-Al, B8 and DR3 were specifically analysed because o f their close 
linkage to TNF .308 A in Europeans (Wilson et a i,  1993) but they were not associated with 
TNF .308 A in this population.
Table 4. HLA phenotypes associated with the TNF .308 A allele (Peon- : P value corrected for 
multiple comparisons).
TNF.308 A + . TNF .308 A - Odds Ratio
(i.e., TNF.308 G 
homozygotes)
B70+ 43 39
B70- 140 345
2.7, Peo,r-0.0009
B50+
B50-
19
164 376
5.5, Peo.T^O.0005
Cw2+
Cw2-
44
139
39
345
2.8, /%,,=0.0005
DRB 1*13.02+ 
DRB 1*13.02-
148
295
234
788
1.7,Peon=0.0005
DRB1*11.01+
DRB1*11.01~
117
326
112
910
2.9, Peon" 1 .3 X 10-1 2
DRBN13.03+
DRB1*13.03- 435
56
966
0.3, Pe„,-r=0.03
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The frequencies o f the TNF.^os A allele -linked HLA class I and class II phenotypes in mild 
non-malaria controls and cases of cerebral malaria are shown in Tables 5 and 6. Homoygote 
and heterozygote frequencies were analysed separately because we specifically wanted to 
exclude the possibility that the increased disease susceptibility o f TNF .308 A homozygotes 
could be attributed to an HLA association. The HLA alleles that were positively associated 
with TNF.308 A were not associated with increased susceptibility to cerebral malaria, and 
the negatively-associated HLA allele was not associated with protection.
Table 5. Frequency of HLA class I types associated with TNF.308 A in mild non-malaria 
controls and cases of cerebral malaria.
B70
B50
Cw2
Controls (^=144) 
Apparent Heterozygotes 
homozygotes
3.5 
0.0 
04 2)
1 1.8 
2.8 
7.6
Cerebral malaria (//=215) 
Apparent Heterozygotes
homozygotes 
0.5 
0.5 
(6 0)
14.0 
5 I 
11.2
Table 6. Frequency of HLA class II types associated with TNF.jos A in mild non-malaria 
controls and cases o f cerebral malaria.
D RBP 13.02
Controls (/7=325) 
Homozygotes Heterozygotes
4.6 24.;
Cerebral malaria (//=374) 
Homozygotes Heterozygotes
1.3 24.1
D R B P l l . O l 0.0 14.8 0.0 15.5
DRBP13.03 0.0 ;.4 0.0 5.1
23
Analysis o f  possible interactions between TTVF.^ o^ ' ^  and HLA-B53 
HLA-B53 is associated with protection from severe malaria in this population. Typing of 
636 Gambian children without malaria showed that the frequency o f  the TNF .308 A 
phenotype was slightly lower in HLA-B53 positive than HLA-B53 negative individuals, but 
this was not statistically significant (42/148 vei'sns 152/488; odds ratio=0.88, P=0.52), that 
is, there was no evidence o f a strong negative association between TNF .308 A and HJ^A- 
B53. The data in Table 7 show the relationship between TNF-308 A homozygote frequency 
and disease severity, after stratifying for HLA-B53 phenotype. When these stratified data 
were analysed by Mantel-Haenszel test, TNF.308 A homozygotes had a relative risk 
(compared to mild non-malaria controls) of 4.1 for cerebral malaria {X^ =5.7, P^0.02) and 
7.0 for death or sequelae due to cerebral malaria (A^=9.3, 7^=0.002), showing that the 
TNF .308 A association is independent o f HLA-B53.
Table 7, TNF.308 A homozygote frequencies by clinical category, stratified by ITLA-B53 
phenotype.
HLA-B53 positive 
TNF.308 A 
n homozygotes
%
HLA-B53 negative 
TNF.308 A 
n homozygotes
%
Mild non-malaria 2.2 233 0.9
Mild malaria 80 0.0 251 2.4
Cerebral malaria 
All cases 59 6.8 308 1.9
Deaths and sequelae 20 10.0 73 6.8
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Discussion
Several features suggest that this polymorphism in the TNF gene may be a causal 
predisposing factor for cerebral malaria. The available evidence from transfection studies 
indicates that the TNF-308 A allele acts to increase the transcription o f TNF (Wilson el a i,
1994). This is consistent with our observation that homozygotes for the TNF-308 A allele 
are at increased risk for cerebral malaria, as we have previously found that Gambian 
children with cerebral malaria have higher TNF levels than children with mild malaria 
(Kwiatkowski et al., 1990). TNF levels are highest in those children who die or develop 
neurological sequelae due to cerebral malaria and it is in this group that we found the 
highest frequency o f TNF .308 A homozygotes. The lack of an association with severe 
malaria anaemia is consistent with the view that acute excess of TNF production is 
specifically involved in the pathogenesis of cerebral malaria, rather than severe malaria in 
general (Kwiatkowski, 1992).
We recognise that the TNF .308 A allele could be associated with some other allele affecting 
TNF regulation, although only one other polymorphism in the TNF gene has so far been 
described, at position -238 nucleotides relative to the transcriptional start site (O'Alfonso & 
Richiardi, 1994). We sequenced the region o f the TNF gene that is most likely to be 
involved in transcriptional regulation (Goldfeld el a i,  1990, 1991; Rhoades et al., 1992) in 
20 individuals who were typed by PCR as TNF .308 A homozygotes. This sequence included 
much o f the promoter as well as the 5' untranslated region. No polymorphisms were found 
other than the single base substitution at position -308.
As the TNF gene is located at approximately 250 kb centromeric of FÏLA-B and 1Mb 
telomeric o f HLA-DR (Dunham et al., 1987), we considered the possibility that this 
association could be due to linkage disequilibrium with neighbouring HLA class I or class II 
antigens. We found that HLA-B70, B50, Cw2, D R B P  13.02 and D R B P  11.01 were 
associated with the TNF.3Ü8 A allele in our study population, yet none of these HLA types 
was associated with susceptibility to cerebral malaria . Conversely, D R B P  13.03 was 
negatively associated with the TNF .308 A allele but was not associated with protection.
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We specifically analysed the relationship of TNF .308 A with HLA-B53, which is associated 
with resistance to severe malaria in Gambian children (Hill et al., 1991). In 636 children 
without malaria we found only a weak negative association between these two alleles 
(which was not statistically significant), and a. Mantel-Haenszel test confirmed that the 
association of TNF .308 A with cerebral malaria is independent o f HLA-B53 status. Several 
lines of evidence indicate that these two neighbouring alleles affect malaria outcome 
through entirely different mechanisms. The protective effect o f HLA-B53 seems to be 
equally strong for homozygotes and heterozygotes, whereas the TNF.308 A association is 
confined to homozygotes. HLA-B53 is protective against both cerebral malaria and severe 
malaria anaemia, whereas the TNF .308 A allele is only associated with cerebral malaria. 
Excessive T N F production is thought to have a specific role in the pathogenesis o f cerebral 
malaria (Clark e /a /., 1987; G rm e ta l.,  1987; Berendt c/nr/., 1989; C la rk e /<7 /., 1992), 
while HLA-B53 probably acts by promoting an effective cytotoxic T-cell response against 
the parasite in the pre-erythrocytic stage o f infection (Hill et al., 1992).
Malaria has been a powerful agent for the selection of genetic polymorphisms which protect 
the host against severe complications of the infection. The TNF .308 A allele exists at a gene 
frequency of 0.16 in The Gambia despite its association with cerebral malaria, implying that 
the disadvantage for TNF.308 A homozygotes is counter-balanced by some biological 
advantage. This may well be in relation to host-defence, as TNF promotes a variety o f anti­
microbial mechanisms in malaria and other infections (Kwiatkowski, 1989; Titus et a i ,
1991 ; Grau et al., 1992; Wong et al., 1992). It is possible that the TNF .308 A allele is 
maintained because heterozygotes possess an optimal level o f TNF response against a broad 
range o f infections; alternatively it is possible that TNF.308 A homozygotes are themselves 
protected against life-threatening conditions other than cerebral malaria.
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Severe malarial anaemia and cerebral malaria are 
associated with different TNF promoter alleles
^McGuire, W., ^Knight, J.C., ^Hill, A.V.S., ^Allsopp, C.E.M., ^Greenwood, B.M. 
& ^Kwiatkowski, D. (1998). Journal o f  Infectious Diseases, in press.
^Department o f  Paediatrics and ^Nuffield Department o f  Medicine, 
Institute o f  Molecular Medicine, John Radcliffe Hospital, Oxford, UK; 
'^Medical Research Council Laboratories, Fajara, The Gambia
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Sunimai-y
Experimental evidence implicates TN F in the pathogenesis o f malarial anaemia, but there 
are few data relating to this hypothesis. We report that severely anaemic children with 
Plasmodium falciparum  infection have low plasma T N F levels, in contrast to the high levels 
found in cerebral malaria. A previous case-control study in The Gambia found cerebral 
malaria, but not severe malarial anaemia, to be associated with the TNF-308 A allele. Here 
we report that in the same population severe malarial anaemia is associated with the TNF .238 
A allele with an odds ratio o f 2.5 (P=0.0006) after stratification for HLA type. These 
findings suggest that severe malarial anaemia and cerebral malaria are influenced by 
separate genetic factors situated in the neighbourhood of the TN F gene.
Introduction
Around half a million African children die each year as a consequence o f severe malarial 
anaemia. However, although most children in sub-Saharan Africa are repeatedly infected 
with Plasmodium falciparum, life-threatening anaemia develops in only a minority. It is 
unclear which factors predispose these children to become markedly more anaemic than 
others (Greenwood et al., 1991).
The pathogenic process is o f malarial anaemia is multifactorial and is only partly explained 
by direct destruction o f eiythrocytes by parasites (Weatherall, 1993). Previous studies in 
The Gambia have indicated that suppression o f erythropoiesis may be o f additional 
importance. Many children with severe anaemia were found to have a depressed 
reticulocyte response, and a significant proportion o f children had gross morphological 
abnormalities of erythropoietic cells in the bone marrow (Abdalla et a i,  1980), Several lines 
of experimental evidence indicate that erythropoiesis can be severely disrupted by 
inflammatory mediators such as TNF. In vitro, TNF suppresses proliferation of eiythroid 
progenitor cells in human marrow cultures (Roodman ei a i ,  1987). In vivo, ei-ythropoiesis 
is inhibited by chronic exposure to TNF, achieved by implanting nude mice with TNF- 
secreting CHO cells (Johnson et al., 1989). TNF has been specifically incriminated as a 
cause o f dyserythropoietic anaemia in experimental murine malaria, which recovers
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following administration o f anti-TNF antibodies (Clark & Chaudhri., 1988; Miller el a i ,
1989). TNF can also promote erythrophagocytosis, as shown by a transgenic murine model 
in which TNF was constitutively over-expressed (Taverne et. a i ,  1994).
In a large case-control study in Gambian children, the HLA class I allele, 1TLA-B53, and the 
class II allele, HLA-DRB 1*1302, have been shown to be associated with protection from 
severe malarial anaemia (Hill et a!., 1991a) These alleles are located 0.25 Mb telomeric and 
1 Mb centromeric of the TNF gene respectively. In view of the evidence that TNF may play 
a role in the pathogenesis of malarial anaemia, we have examined the relationship of severe 
anaemia to plasma TNF levels and to TNF promoter alleles in the same population of 
Gambian children.
Subjects and Methods
Children aged up to 10 years were enrolled into a case-control study o f severe malaria 
based at the Royal Victoria Hospital, Banjul, and the Medical Research Council Clinic, 
Fajara in The Gambia, between 1988 and 1990. Severe malarial anaemia was defined as 
haemoglobin <5g/dl in association with asexual P. falcipannii parasitaemia of >2500/ul. 
Cerebral malaria was defined as a Blantyre coma score <3 (persisting for >30 minutes after 
effective treatment of hypoglycaemia or convulsions) or repeated prolonged seizures (>30 
minutes) in a child with P. falciparimi parasitaemia and no other apparent cause o f fits or 
coma.
The severe malaria group was matched to two control groups for age and area o f residence 
around Banjul. The primary control group was children who were being treated as 
outpatients for minor illnesses other than malaria, predominantly respiratory and 
gastrointestinal infections (‘mild non-malaria’ control group). The second group was 
children with an uncomplicated febrile illness associated with asexual P. falciparum  
parasitaemia (‘mild malaria’ control group). Further details o f the case-control study are 
reported elsewhere (Hill et a i,  1991a; Kwiatkowski et a!., 1990).
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Lahorafory methods
Plasma TNF levels were measured by enzyme linked immunosorbant assay (ELISA), and 
the TNF-308 A allele was typed by PCR and allele-specific oligonucleotide probing, both as 
previously described (Kwiatkowski et al., 1990; Chapter II).
The more recently defined TNF promoter variant, a G-A transition at position -238 
nucleotides relative to the transcriptional start site (D’Alfonso & Richiardi, 1994) was 
typed by amplification refractory mutation system PCR using a conserved primer 5'- 
CCGGATCATGCTTTCAGTGC-3' together with sequence-specific primers for either the 
TNF-238 G allele(5'-AGACCCCCCTCGGAATCG-3') or the TNF .238 A allele (5'- 
AAGACCCCCCTCGGAATCA-3’) to generate 459 and 460 base-pair products 
respectively. As a positive control, each reaction mixture contained the primers 5'- 
CCAAAGATTCAGGTTTACTCACG-3' and 5'-ACTTAACTATCTTGGGCTGTGAC-3' 
to amplify a 266 base-pair fragment of the beta 2 microglobulin gene (Gessow et al., 1987). 
Each 25ul reaction mixture contained approximately lOOng of genomic DNA, 67mM Tris- 
HCl, 16mM (NIT,)2S0 4 , 2mM MgCb, lOOuM of each dNTP (Boehringer Mannheim, 
Germany), 0.01% Tween-20, 0.5 units of Taq DNA polymerase (Bioline, UK), 0. luM of 
each TNF primer and 0.2uM each beta 2 microglobulin primer. The mixture was incubated 
at 95°C for 10 minutes, followed by 5 cycles o f 95°C for 1 minute, 6TC  for I minute, 72"C 
for 1 minute, then 25 cycles of 95°C for 1 minute, 62”C for 1 minute, 72"C for 1 minute 
then a final 10 minutes at 72"C. The products were resolved in 2% agarose gel, stained with 
ethidium bromide and visualised under UV light.
Direct DNA sequencing of the PCR product was used to confirm the validity of the typing 
methods. Following purification through a microcon 100 column (Amicon, USA), PCR 
amplified genomic DNA was cycle sequenced using the ABI PRISM dye terminator kit 
(Perkin Elmer, USA) using primer 5'-TTTCCTGAGGCCTCAAGCCT-3' and analysed on 
an ABI377 automated sequencer.
HLA types were initially determined serologically (class 1) or by restriction fragment length 
polymorphism using Taql digestion with DRB- and DQB-specific probes (class II). Further 
analysis of HLA types was done by allele-specific oligonucleotide hybridisation of PCR
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products following generic amplification of either the HLA-A, B and C region or the HLA- 
D region (Wordsworth et a!., 1990).
Statistical analysis
Continuous data were compared by Mann Whitney U test. Clinical groups were otherwise 
compared by test, using stratified Mantel-Haenszel analysis to correct for the possible 
confounding effects of ethnic heterogeneity and linkage with HLA class I and ÏÏ alleles.
Ethical approval
All aspects o f the study were approved by the Gambia Government / Medical Research 
Council Joint Ethical Committee.
Results
Table 8 compares the clinical profile and plasma TNF levels of children with severe malarial 
anaemia, cerebral malaria or mild malaria. Data are presented on a subset of.the total study 
population as plasma TNF was measured only for those subjects from whom a blood 
sample was taken immediately after admission to hospital, We found no significant 
difference in the plasma TNF levels in children presenting with severe malarial anaemia 
compared to those with mild malaria. This contrasts with our previous finding of elevated 
plasma TNF levels in Gambian children with cerebral malaria (Kwiatkowski et al., 1990).
With regard to the presenting features o f children in each clinical category, for simplicity, 
children who satisfied the case definition for both cerebral malaria and severe malarial 
anaemia are omitted from the comparison (table 8). The median age o f children with severe 
malarial anaemia was lower than those with cerebral malaria (F<0.001) or with those with 
mild malaria (F<0.001). The severely anaemic group reported a significantly longer 
duration of symptoms than children with uncomplicated malaria fever (F<0.001) or cerebral 
malaria (F<0.001). A larger proportion o f children with severe malarial anaemia were found 
to have splenic enlargement (F<0.001) and the geometric mean parasitaemia level on 
presentation was lower in the anaemic group compared with those with mild malaria 
(/NO.OOl).
The TNF .238 A allele was found in Hardy-Weinberg equilibrium at a frequency o f 
approximately 0.06 in both o f the control groups o f Gambian children. We found an excess 
o f the TNF .233 A allele in children with severe malarial anemia when these were compared 
to either the non-malaria control group (odds ratio 1.7; 95% Cl 1.02-2.8; P -  0.04, Mantel- 
Haenszel weighted for ethnic group) or to the mild malaria control group (odds ratio 
1.9; 95% Cl 1.1-3.1 ; 0.02) (Table 9). We found no association o f the TNF .238 A allele
with cerebral malaria, which contrasts with our previous finding for the TNF promoter 
TNF.308 A allele, where we reported an association of the TNF.308 A homozygous state 
with cerebral malaria but not severe malarial anaemia (Chapter II). The TNF .308 A and 
TNF .238 A alleles were not linked in this population and the relationship between the TNF 
.238 A allele and severe anaemia was unaffected by stratification for the TNF .308 genotype.
On analysis of associations between the TNF .238 genotype and alleles in the HLA class I 
and class II regions, we found the TNF.238 A allele to be in linkage disequilibrium with 
HLA-B53 (OR=3.9, P < 10'^), an unexpected result since HLA-B53 is known to be 
associated with protection against severe malarial anaemia in this population (Hill et a i,  
1991a). Correction for HLA-B53 status served to strengthen the association between the 
TNF .238 A allele and susceptibility to severe malarial anaemia (comparing severe malarial 
anaemia group with non-malaria control group, odds ratio rises from 1.7 to 2.5; F=0.0006, 
Mantel-Haenszel X^ stratified for presence or absence o f HLA-B53). Conversely the 
relationship between HLA-B53 and protection from severe malarial anaemia was 
strengthened by correction for TNF.238 genotype (odds ratio falls from 0.42 to 0.32;
F=0.00004, Mantel-Haenszel X^ stratified for presence or absence o f TNF .238 A).
HLA-DRB 1 * 1302, which is associated with protection against severe malarial anaemia in 
The Gambia (Hill et a!., 1991a) was found to be negatively linked to the TNF .238 A allele 
(odds ratio 0.46, P=0.0002). Linkage disequilibrium was also shown for HLA-B18 (odds 
ratio 17.9, F<10'^) and HLA-DR9 (odds ratio 7.1, F<10'^), neither o f which is associated 
with severe malaria in The Gambia, Stratification for these alleles did not affect the 
association of the TNF .238 A allele with severe anaemia.
Table 8. Clinical features and laboratory investigations of Gambian children presenting with 
malaria of different severity. Continuous data are presented as mean value, or geometric 
mean for parasitaemia, with 95% confidence intervals in parenthesis.
mild malaria cerebral malaria severe malaria
alone anemia alone
n 191 166 63
Hb (g/dl) 8.7 (8.4-9.0) 8.3 (8 0-8.6) 4.3 (4.0-4.6)
age (years) 4.2 (4.0-4.4) 4.1 (3.9-4.3) 2.2 (2,0-2.4)
duration o f symptoms (days) 3.7 (3.3-4.1) 2.7 (2.4-3.0) 50 (4 .1 -5 .9 )
spleen >2cm (% of cases) 1 % 14% 12%
parasitaemia (x 1 oVL) 59(47-73) 64 (44-93) 30 (17-54)
TNF (pg/ml) 18 (15-21) 57 (43-78) 3 (8-20)
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Discussion
The pathogenic process o f severe malarial anaemia is complex and incompletely 
understood. In many cases, the clinical features are consistent with prolonged infection due 
to poorly developed anti-malarial immunity. Our hypothesis is that chronic low-grade 
production o f TNF, in response to P.falciparum  parasitaemia, induces dyserythropoiesis 
and contributes to the pathogenesis o f malarial anemia. We have found plasma TNF levels 
not to be elevated in children presenting with severe malarial anemia compared to those 
with uncomplicated malaria fever. However, because o f the relative chronicity o f the illness, 
as compared to the typically acute presentation o f cerebral malaria, and the short circulating 
half-life of TNF, standard plasma TNF measurements may be expected to shed little light on 
the question of whether severe anemia might result from excessive TNF production. Since 
it is extremely difficult to quantitate the production rates of TNF by plasma measurements, 
and since it is not feasible to obtain bone marrow histology on the majority o f patients, we 
opted to address this problem by examining for associations o f severe malarial anemia with 
polymorphic markers in the TNF promoter region.
We found the TNF.?;* A allele to be associated with susceptibility to severe malaria! 
anemia, but not to cerebral malaria. In contrast, in the same population, we have previously 
found the neighboring, TNF.308 A allele to be associated with cerebral malaria, but not with 
severe malarial anemia (Chapter II). Taken together, these findings suggest that the clinical 
outcome o f malaria is influenced by complex genetic determinants in the neighborhood of 
the TNF gene. Linkage disequilibrium of the TNF .238 A allele with several HLA alleles was 
identified but none of these account for the association with susceptibility to severe malarial 
anemia. O f particular note, we found the TNF .238 A and HLA-B53 alleles to be linked but 
their effects on susceptibility to severe malarial anemia work in opposite directions. This 
raises the intriguing possibility that in this case natural selection has favored a haplotype 
that balances the risks of one immunological characteristic against the benefits of another.
The location of the TNF .238 A allele in the TNF promoter region raises the possibility that it 
could influence constitutive TNF production directly (D’Alfonso & Richiardi, 1994).
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However, a study o f the TNF .238 A allele at the cellular level failed to reveal an effect on 
TNF response to short term stimulation with bacterial lipopolysaccharide (Pociot ct al.,
1995). Thus, as may be the case with the TNF .308 A allele, the TNF .238 A allele may serve 
as a marker for a functional polymorphism elsewhere in the TNF gene or in another nearby 
immunologically relevant gene. As TNF transcriptional regulation is known to be cell-type 
and stimulus specific (Tsai et al., 1996), further studies are required to determine the true 
functional importance of the allele in the context o f chronic stimulation by P. falciparum.
These findings in malaria relate to a general problem in the pathogenesis o f infectious 
disease. There is clear evidence that TNF mediates acute symptoms such as fever and septic 
shock. From experimental evidence it appears probable that TNF also contributes to the 
cachexia and anemia of protracted infection and this finding of an association between a 
polymorphic marker in the TNF promoter region and malarial anemia lends weight to this 
hypothesis. Further association studies in genetically distinct populations and studies in 
family groups would help to define precisely the genetic elements involved.
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Levels of tumour necrosis factor and soluble TNF receptors 
during malaria fever episodes in the community
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Siinimaiy
The pyrogenic cytokine, TNF, is a mediator o f malaria fever. Since high plasma levels of 
TNF are sometimes found in afebrile individuals with Plasmodium falciparum  parasitaemia, 
it has been suggested that soluble forms o f TNF receptors (sTNF-R55 and sTNF-R75) in 
the plasma may act to inhibit the pyrogenic effect o f TNF. We have investigated plasma 
levels of TNF, sTNF-R55 and sTNF-R75 in relation to episodes o f malaria fever detected in 
a cross-sectional study o f 313 rural Gambian children during the malaria transmission 
season. Levels of TNF were significantly higher in the 20 children who had parasitaemia 
associated with fever compared to 120 children who were afebrile despite malaria infection 
and 173 who had no detectable parasitaemia. In contrast, soluble TNF receptor levels did 
not differ between these clinical groups and, in a logistic regression model which included 
level of parasitaemia, we found TNF but not soluble TNF receptor levels to be associated 
with the presence o f fever. These data support the role of TNF in malaria fever but suggest 
that soluble TNF receptors are not a major factor in modulating the fever.
Introduction
The immunological processes that lead to clinical tolerance o f malaria infection are poorly 
understood. Fever, the predominant symptom o f malaria, is caused by factors released at 
schizont rupture (Golgi, 1889) that stimulate the host to produce TNF and other pyrogenic 
cytokines (Kwiatkowski el a i, 1989; 1993). However, elevated levels o f TNF have been 
detected in the plasma of children with P. falciparum  infection when they are afebrile 
(Peyron el a i, 1990; Mshana et a i, 1991). Similarly it has been proposed that TNF is a 
major factor in the pathogenesis of cerebral malaria, and several studies have demonstrated 
an association between high plasma TNF and malaria disease severity, yet there is 
considerable overlap in the TNF levels between those with mild and those with severe 
disease (Clark, 1987; Grau et a i,  1989; Kwiatkowski et a i,  1990). These observations 
raise the question of whether clinical tolerance might arise, at least in part, from inhibitory 
factors that modulate the biological activity o f TNF in the circulation o f the infected 
individual.
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One such mechanism could be the production o f  inhibitory TNF-binding proteins. The two 
cell-surface receptors for TNF also exist as soluble forms, termed sTNF-R55 and sTNF- 
R75, and these are present in the plasma o f malaria patients (Kern et a i, 1992; Molyneux et 
a i, 1993). There is evidence o f inhibition o f the biological activity o f TNF by sTNF-R55 
and STNF-R75 in vitro (Seckinger et a i ,  1988; Engelmann et a i ,  1990) raising the question 
o f whether they act to modulate the clinical effects of TNF bioactivity in the context o f 
natural infection. This study considers the possibility that soluble TNF receptors might act 
to modulate the pyrogenic effect o f TNF in malaria, thus explaining why some parasitaemic 
individuals seem to tolerate high circulating levels of TNF while remaining afebrile. We 
measured plasma TNF, sTNF-R55 and sTNF-R75 in a cross-sectional sample o f rural 
Gambian children during the malaria transmission season, to determine their respective 
associations with malaria fever episodes in a natural endemic setting.
Subjects and Methods
During the malaria transmission season (October-November 1992), a cross-sectional 
clinical survey o f a random sample of 313 rural Gambian children, aged 1-4 years, was 
undertaken (see D'Alessandro et a i ,  1995c for details). The epidemiology of malaria in 
rural Gambia has been described previously (Thomson et a i, 1994). The children were 
examined, their axillary temperature measured and a fmger-prick blood sample collected 
into tubes containing sodium ethylenediaminetetraacetate (Img/ml) and aprotinin (0.5 
trypsin inhibitor units/ml). Plasma was separated immediately by centrifugation at 10000 g  
and stored frozen until assayed. Thick blood films were stained with Field’s stain and 
parasitaemic individuals treated appropriately. A second thick film was stained with 
Giemsa’s stain and 100 microscope fields were examined (xlOOO); parasite density was 
estimated assuming that one parasite per field is equivalent to 500/ul (Greenwood & 
Armstrong, 1991).
hJeastiremenl o f TNF and sTNF-Rs
TNF levels were measured by an immunoradiometric assay (IRMA; Medgenix, Belgium) as 
described previously (Kwiatkowski et a i,  1993). This detection system measures total 
plasma TNF, including TNF already bound to soluble receptors (Engelberts et a i, 1991).
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The lower limit o f detection o f the IRMA was 15pg/ml and for statistical purposes values 
less than this were coded as 10pg/ml.
Plasma sTNF-R55 and sTNF-R75 were assayed by separate enzyme linked immunosorbant 
assays (Gardiner ei a i,  1995). Briefly, microtitre plates were coated with the relevant 
capture monoclonal antibody (murine anti-human sTNF-R55 or -R75). Samples and serial 
dilutions o f standards were then added. After incubation and washing, a second biotin- 
conjugated murine monoclonal antibody against human sTNF-R55 or sTNF-R75 was 
applied. After further incubation and washing a streptavidin-horse radish peroxidase 
conjugate was added, incubated, then washed before tetramethylbenzidine substrate was 
added. The optical density at 630nm (reference 420nm) of the developed product was 
measured and levels o f receptor estimated by interpolation on a standard curve. Under these 
conditions, the lower limit of detection was 0.5ng/ml for sTNT-R55 and 5ng/ml for sTNF- 
R75. For statistical purposes values below these were attributed concentrations o f 0.2ng/ml 
and 2ng/ml respectively. The antibodies were the gift o f Celltech Limited, UK.
Assays were performed on samples subjected to no more than two freeze-thaw cycles.
Statistical analysis
Means were compared between groups by Mann Whitney U tests and correlations by 
Spearman’s rank correlation.
Ethical approval
All aspects of the study were approved by the Gambia Government / MRC Joint Ethical 
Committee. Prior consent was obtained from the guardians o f all children included.
Results
In all, 313 children, 51% female, were studied. The median age was 2.4 years. The most 
common ethnic group was Mandinka (33%), followed by Tula (23%), Sarahuli (19%), Jola 
(17%), and Wollof(6%).
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Clinical Profile
Three clinical categories were defined. The first category included 20 children (6.4% of the 
study population) who had detectable asexual parasitaemia associated with an axillary 
temperature of >37.5"C and no other obvious cause o f fever (P+F+). The second category 
was 120 children (38.3%) who were afebrile despite infection with P.falciparum  (P+F-). 
The third category was 173 children (55.3%) who had no detectable parasitaemia (P-). 
Three of the aparasitaemic individuals had axillary temperatures greater than 37.5°C. There 
was no difference in age, sex or ethnic group distribution between these groups.
The geometric mean parasite count was significantly greater in the P+F+ group (14660/ul, 
95% confidence inteiwal 5901- 36421) than in the P+F- group (610/ul, 95% Cl 366- 1016; 
P<0.001).
Relaiionship o fl 'N F a n d s  TNF-Rs to parasitaemia and fever
There was a significant positive association between level of parasitaemia and levels of TNF 
(r, -  0.32, P <0.001), STNF-R55 (r, = 0.24, P <0.01) and sTNF-R75 (i\ -  0.26, P <0.01) 
(Fig. 2).
Geometric mean levels o f TNF were higher in the P+F+ group (51 pg/ml) than in the P+F- 
group (21 pg/ml; f<0.001), and higher in the P+F- group than in the P- group (21 pg/ml 
versus 15pg/ml; P = 0.003). In contrast, neither sTNF-R55 nor sTNF-R75 levels differed 
significantly among the 3 clinical categories (Fig.3).
To examine whether soluble TNF receptor levels affected the association between TNF and 
fever in parasitaemic children, we used a logistic regression analysis. When the analysis was 
restricted to TNF, sTNF~R55 and sTNF-R75, the only significant predictor o f fever was 
TNF, suggesting that soluble TNF receptor levels do not significantly affect the ability of 
TNF to induce fever in this clinical context (Wald coefficient 8.8, F=0.003; all variables 
were logarithmically transformed). Importantly, TNF remained a significant predictor of 
fever after correcting for level o f parasitaemia by including this in the logistic regression 
model (Wald statistic for parasitaemia 9.2, P=0.002\ Wald statistic for TNF 4.0, 7^=0.045; 
all variables were logarithmically transformed).
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Fig. 2. Mean temperature and geometric mean levels o f  TNF, sTNF-R55 and sTNF-R75 in 
relation to parasite density. 173 children had no parasites, 122 had <5000 parasites/ul, and 
18 had >5000 parasites/ul Error bars represent 95% confidence intervals.
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Fig. 3. Geometric mean levels of TNF, sTNF-R55 and sTNF-R75 in relation to clinical 
categoi-y. 173 children had no parasites (P-), 120 had parasitaemia but were afebrile (P+F-), 
and 20 had parasitaemia with fever (P+F+). Error bars represent 95% confidence intervals.
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Discussion
In this community-based study o f rural Gambian children we found elevated circulating 
TNF levels to be associated with episodes o f malaria fever. This association held true after 
correction for level o f parasitaemia in a logistic regression model, and it was not affected by 
plasma levels o f the soluble TNF receptors, sTNF-R55 and sTNF-R75. These data 
complement a growing body of evidence that TNF mediates malaria fever, but do not 
support the hypothesis that inhibitory TNF-binding proteins are an important mechanism of 
clinical tolerance in African children with malaria.
Several lines of evidence support the role o f TNF as a critical mediator of malaria fever: it is 
a potent endogenous pyrogen (Dinarello et al,. 1986) which is released by human peripheral 
blood mononuclear cells in response to schizont rupture (Kwiatkowski et ai, 1989), and 
monoclonal anti-TNF antibodies suppress fever in children with cerebral malaria 
(Kwiatkowski et a!., 1993; Boele van Hensbroek et a i,  1996). In P.vivax malaria, a 
temporal relationship has been demonstrated between elevated plasma TNF and fever 
paroxysms, by sequential clinical measurements before the commencement o f antimalarial 
y trea^n en t (Karunaweera et a i, 1992). Such temporal correlations are more difficult to 
investigate in P. falciparum  infection, partly because fever paroxysms are less clearly 
defined, but also because it is not acceptable to delay antimalarial treatment once a 
diagnosis of symptomatic falciparum malaria has been made. We therefore examined a 
random cross-section o f rural Gambian children during the malaria transmission season, 
expecting that a significant proportion would be found to be parasitaemic and that some of 
these would be at a febrile stage of the infection. We investigated children aged 1 to 4 years 
as this group bears the brunt of malaria morbidity in The Gambia (Greenwood el a l ,  1987). 
Information obtained from this cross-sectional sample should represent events at the 
various stages in the natural history of P.falciparum  infection as it is likely that a proportion 
of the afebrile parasitaemic children would have been febrile in previous days or would have 
become febrile subsequently (Trape et a i ,  1985).
It is likely that a variety o f infectious agents contribute to increased TNF production in this 
population, but these data indicate that malaria is a predominant cause since plasma TNF
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levels were significantly correlated with parasite density at the community level. We found 
that plasma TNF levels are significantly higher in children who are both parasitaemic and 
febrile at the time of examination, compared to those who are parasitaemic but afebrile. 
Although parasitaemia was significantly lower in the latter group, logistic regression 
analysis indicated that at least part o f the association between TNF and fever was 
independent o f the level o f parasitaemia.
The TNF assay method employed in this study gives an indication o f total circulating TNF 
levels and has been shown to be relatively unaffected by the presence o f soluble TNF 
receptors (Engelberts et a i,  1991). We detected sTNF-R55 and sTNF-R75 levels in the 
ng/ml range, which represents a 100-1000 fold molar excess over TNF in the plasma, yet 
the data provide no evidence that these inhibitory binding proteins act to modulate the 
pyrogenic effect o f TNF in malaria infected individuals. That is, amongst children who were 
parasitaemic, soluble TNF receptor levels did not differ significantly in those who were 
febrile compared to those who were not. Furthermore, inclusion o f sTNF-R55 and sTNF- 
R75 levels in a logistic regression model did not weaken the association of TNF level with 
fever. Thus we are left with our original question o f why some children remain 
asymptomatic despite elevated plasma TNF levels. A possible technical explanation might 
be that artefactual elevation o f TNF can result from the presence o f rheumatoid factors or 
other components that crossreact with TNF immunassays; while a biological explanation 
might be that malaria fever depends on synergy between a number of different pyrogenic 
cytokines, of which TNF is simply the best-studied example.
The function of soluble TNF receptors in the context o f malaria remains unclear. Even in 
healthy individuals sTNF-Rs are found in plasma at ng/ml concentrations (Aderka et a!., 
1992a). They are derived by proteolytic cleavage from the cell surface forms (Nophar et a!.,
1990). TNF itself is thought contribute to TNF receptor cleavage (Lantz et al., 1990) and 
our obsei-ved correlation o f TNF with sTNF-R55 and sTNF-R75 levels would be consistent 
with this mechanism. It may be that the soluble receptors act to buffer the endocrine effects 
of circulating TNF (Spinas et al., 1992), but there is also experimental evidence to suggest 
that in some circumstances they might act to prolong the bioactive half-life o f TNF within 
the circulation (Aderka et al., 1992b).
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Although this is the first study to investigate the possible effect o f soluble TNF receptors on 
malaria fever symptoms, it has been previously documented that high levels are found in 
patients with severe complications ofT. falciparum  infection (Kern et a l ,  1992; Molyneux 
et a l ,  1993; Kremsner et a l ,  1995). In the latter two studies, in Malawian and Gabonese 
children respectively, it was noted that the ratio o f TNF to soluble TNF receptors was 
higher in severe than in uncomplicated malaria, and on this basis it was suggested that 
soluble TNF receptors may act to attenuate the serious adverse effects of TNF in malaria. 
However, it is difficult in falciparum malaria to obtain the detailed sequential data that 
might allow investigation o f the dynamic interplay between TNF and its soluble receptors, 
prior to the onset o f severe symptoms. The physiological function o f circulating soluble 
TNF receptors in malaria and other infectious diseases remains a matter o f considerable 
clinical interest.
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Circulating ICAM-1 levels in falciparum malaria 
are high but are unrelated to disease severity
’McGuire, W., ^Hill, A.V.S.,. "'Greenwood, B.M. & ’Kwiatkowski, D. (1996). 
Transactions o f  the Royal Society o f  Tropical Medicine and Hygiene, 90, 274-276.
^Department o f  Paediatrics and ^Nuffield Department o f  Medicine, 
Institute o f  Molecular Medicine, John Radcliffe Hospital, Oxford, UK: 
'Medical Research Council Laboratories, Fajara, The Gambia.
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Summai’y
Intercellular adhesion molecule-1 (ICAM-1) mediates the binding o f Plasmodium  
falciparum  to vascular endotheliurg^n a case-control study of falciparum malaria in 
Gambian children, we have looked for evidence that a generalised increase in expression of 
ICAM-1 is associated with cerebral malaria. Plasma levels of circulating ICAM-1 (cICAM- 
1) were significantly higher in 246 children with acute malaria than in 156 children with 
non-malarial illnesses. cICAM-1 levels correlated with levels of TNF, interleukin-1 alpha 
(IL-1) and interferon-gamma, supporting the view that these cytokines are responsible for a 
general up-regulation o f ICAM-1 expression in malaria. However, while it has been 
previously shown that TNF and IL-1 levels were related to disease severity, this was not the 
case for cICAM-1. It may be that differences in the distribution o f ICAM-1, rather than its 
total level of expression, are critical in determining the clinical outcome in malaria.
Introduction
A major pathological feature o f falciparum malaria is the sequestration of parasitised 
erythrocytes (PRBC) in small blood vessels (MacPherson et al., 1985; Turner et a f ,  1994). 
Cerebral malaria is believed to be a consequence o f this phenomenon occuring in post- 
capillaiy venules in critical areas of the brain. Sequestration is the result o f a specific 
interaction between ligand(s) expressed on the surface o f PRBC and receptors expressed on 
vascular endothelium (Berendt et a i ,  1990). One of the best characterised o f these 
endothelial receptors is intercellular adhesion molecule-1 (ICAM-1) (Berendt et a i ,  1989). 
ICAM-1 is a membrane glycoprotein whose physiological role is to mediate leucocyte 
adhesion by acting as a receptor for two ligands which are variably expressed on the 
leucocyte surface, namely leucocyte function antigen I (LFA-1, CDl 1 a/CD 18) and Mac-1 
(CDl lb/CD 18). The binding site for parasitised erythrocytes is distinct from those of the 
leucocyte integrins (Berendt et a i,  1992; Ockenhouse et a i ,  1992b).
Expression of ICAM-1 on human vascular endothelium can be up-regulated by the pro- 
inflammatory cytokines TNF and IL-1 (Dustin et a i ,  1986). These cytokines are present at 
high levels in the plasma o f African children with malaria and elevated levels are related to
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disease severity and outcome (Kwiatkowski et a i ,  1990). Several investigators have 
pointed out that high levels of TNF and IL-1 production may exacerbate parasite 
sequestration by up-regulating ICAM-1 expression on endothelium and that this may be a 
critical step in the pathogenesis of cerebral malaria (Berendt et a i ,  1990). Flowever, it has 
proved difficult to explore this hypothesis in vivo.
There are obvious difficulties in obtaining a direct measurement o f ICAM-I expression in 
the blood vessels o f children with malaria but an indirect measure o f ICAM-I expression 
may be provided by the amount o f soluble ICAM-1 that is shed into the circulation. Studies 
in vitro have shown that the release o f soluble ICAM-1 correlates with levels o f ICAM-1 
expressed on endothelium in response to TNF and IL-1 (Leeuwenberg et at., 1992).
Soluble (circulating) forms of ICAM-1 (cICAM-1) have been detected in the plasma of 
patients with a variety o f inflammatory disease states (Gearing & Newman, 1993), including 
acute falciparum malaria (Hviid et a!., 1993; Deloron et al., 1994; Graninger et al., 1994; 
Jakobsen et al., 1994).
The present study was designed to test the hypothesis that cerebral malaria in African 
children might be related to a generalised increase in ICAM-1 expression, consequent on 
high levels of TNF and IL-1 production.
Patients and Methods
We studied Gambian children, aged 1-10 years, who attended the Royal Victoria Hospital, 
Banjul or the Medical Research Council (MRC) Laboratories, Fajara in the 1988 rainy 
season. As part of a large case-control study o f cerebral malaria in this population 
(described in detail in Kwiatkowski et al., 1990), venous blood samples were collected 
from 157 children who presented with cerebral malaria {Plasmodium falciparum  
parasitaemia, Blantyre coma score <3, no other cause of coma), o f whom 132 survived the 
episode and 25 died; 89 children with mild malaria {P. falciparum  parasitaemia, axillary 
temperature > 37.4"C, no other cause o f fever); and 156 children with a variety of 
infectious diseases other than malaria (mainly acute respiratory tract and gastrointestinal 
infections of vailing degrees of severity, no malaria parasites seen on a thick blood film).
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Plasma (with ethylenediaminetetraacetatic acid and aprotinin) was separated within one 
hour o f collection and stored frozen at -20"C until assayed. TNF, IL -1 and interferon- 
gamma (IFN) were assayed as described previously (Kwiatkowski et a/., 1990).
cICAM-1 was measured by an enzyme linked immunosorbent assay (British Bio-technology 
Limited, Oxford, UK). Briefly, plasma samples diluted 1:100 in phosphate buffered saline 
were added to polystyrene plates precoated with anti-ICAM-1 mouse monoclonal antibody. 
A biotinylated anti-ICAM monoclonal antibody was added and, after incubation at room 
temperature for 2 hours and extensive washing, streptavidin conjugated with horseradish 
peroxidase was added. After further incubation for hour followed by washing the reaction 
product was developed in tetramethyl-benzidine substrate solution for 10 minutes, after 
which the reaction was terminated with 2N sulphuric acid. The optical density (absorbance) 
at 450nm of the developed product was assayed and cl CAM levels in samples were 
estimated from the standard curve for each assay. The detection limit was 2.5ng/ml and, for 
statistical purposes, results below this limit were assigned values of 1.25ng/ml.
Ethical approval
Ethical approval was obtained from the Gambian Government / MRC Joint Ethical 
Committee.
Results
The median age o f children who survived the episode of cerebral malaria was 3.8 years and 
that o f those who died was 3 .0 years. The median ages in the mild malaria and non-malaria 
groups were 3.4 years and 2.2 years respectively.
Levels of cICAM-l correlated with those o f IL-1 (Spearman rank correlation coefficient, 
/'=0.29, F<0.001), TNF (/-0 .29, F<0.001) and IFN (/-0 .24, F<0.001). Since the plasma 
levels of the cytokines were correlated with each other, we performed a multiple linear 
regression analysis to determine if each cytokine independently correlated with clCAM-1. 
In this model, both IL-1 (F^O.Ol) and TNF (F=0.04), but not IFN, were significant 
predictors of cICAM-1 levels.
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Comparing the group o f children with acute malaria (mild and cerebral) with those with 
non-malarial illness, the geometric mean cICAM-1 level was higher in the malaria group 
(735ng/ml, 95% confidence interval (Cl) 689-8lOng/ml versus 440ng/ml, 95% Cl 395-493; 
f <0.001, by t-test on log-transformed variables). To determine whether this association 
between cICAM-1 with malaria was independent o f the measured cytokines, we did a 
logistic regression analysis o f children with malarial versus non-malarial illnesses against 
TNF, IL-1, IFN and cICAM-1 (all variables log-transformed). The most significant 
correlates of malaria were the levels of TNF (F<0.001) and cICAM-1 (P<0.001).
We found no significant difference in geometric mean cICAM-1 levels in children 
presenting with cerebral malaria (779ng/ml, 95% Cl 704-86 Ing/ml) compared to those with 
mild malaria (685ng/ml, 95% Cl 584-804ng/ml). Similarly, there was no significant 
difference in cICAM-1 levels between those children who survived an episode o f cerebral 
malaria compared with those who died (775ng/ml, 95% Cl 694-865ng/ml versus 801 ng/ml, 
95% Cl 585“1097ng/ml respectively). (Fig. 4). These findings for cICAM-1 are in contrast 
to our findings for TNF (geometric mean level in mild malaria = lOpg/ml, in cerebral 
malaria = 19pg/ml, and in children who die o f cerebral malaria -  99pg/ml) and IL-1 
(lOpg/ml, 17pg/ml and 40pg/ml respectively) in this sample.
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Figure 4. Circulating ICAM-1 level (cICAM-1) in Gambian children presenting with a 
variety of clinical conditions; columns indicate geometric means (logarithmic scale), vertical 
bars indicate +/- one standard error.
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Discussion
It is not known why only a minority o f African children infected with Plasmodium  
falciparum  develop cerebral malaria (Greenwood el a i ,  1991). Parasite virulence factors, 
such as cytoadherence phenotype (Roberts et a i ,  1992), may be important, although to 
date only erythrocyte resetting has been demonstrated to be associated with disease severity 
(Carlson et a i ,  1990). Host factors may also be involved and there has been considerable 
interest in the role o f the host cytokine response in determining the clinical outcome of 
infection. In this population, the plasma levels o f TNF and IL -1 have been shown to be 
independent predictors for cerebral malaria and specifically for a fatal outcome from this 
condition (Kwiatkowski et a i ,  1990). Recently we have demonstrated that Gambian 
children with a genetic propensity to produce higher amounts o f TNF are at increased risk 
o f developing and dying from cerebral malaria (Chapter II). Since TNF and IL-1 upregulate 
expression of ICAM-1, it has been suggested that one way that these cytokines contribute 
to the pathophysiology o f cerebral malaria is by mediating enhanced sequestration of PRBC 
(Berendt el a i,  1990).
Because of the problems involved in obtaining appropriate post-mortem tissue samples it 
has proved difficult to examine the role o f endothelial receptor expression in the 
pathogenesis o f cerebral malaria in African children. We have therefore attempted to 
examine the relationship between cytokine and ICAM-1 expression in this population by 
measuring the level o f circulating plasma ICAM-1 in children recruited to a case-control 
study o f cerebral malaria in The Gambia.
We have found circulating ICAM-1 levels to correlate with plasma levels o f the pro- 
inflammatory cytokines, TNF and IL-l, supporting iu-vilro evidence that these cytokines 
induce enhanced expression and shedding o f ICAM-1 (Dustin el a i ,  1986; Leeuwenberg el 
a i,  1992). cICAM levels were found to be significantly higher in Gambian children with 
falciparum malaria than in comparable children with non-malarial illnesses. If cICAM-1 
levels in plasma do reflect cell-surface expression, as is the case in vitro, then these data 
support previous immunohistochemical evidence o f a cytokine mediated upregulation of 
I CAM-1 expression in acute malaria (Turner el a i ,  1994).
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Unlike a previous, smaller study in The Gambia which found higher levels o f cICAM-1 in 
children with severe malaria (severe malaria anaemia and cerebral malaria) compared to 
children with mild malaria (Jakobsen et al., 1994), these data provide no evidence that the 
overall level of ICAM-1 expression in itself is critical in determining the clinical outcome of 
P. falciparum  infection since we have found cICAM-1 levels not to differ between children 
with cerebral malaria and those with mild malaria. Deloron et al. (1994) also found no 
difference in the cICAM -1 levels in Burundian adults with cerebral malaria compared to 
those with severe malaria without cerebral involvement, and concluded that ICAM-1 was 
not involved in the pathophysiology o f cerebral malaria. Although our data are consistent 
with this interpretation, it may be that when levels of ICAM-1 expression are generally 
high, as in malaria, small regional differences in expression may critically affect the site of 
maximum PRBC sequestration. The tissue distribution o f ICAM-I expression, rather than 
the total level o f expression, may be the more important determinant o f whether an 
individual child develops cerebral malaria. Resolving this issue requires detailed post­
mortem comparisons between patients dying o f cerebral and o f non-cerebral malaria.
Although elevated plasma cICAM-1 in acute malaria may simply reflect receptor shedding 
or de-adherence of sequestered PRBCs (or activated lymphocytes) from endothelium, an 
intriguing question is whether these circulating forms are of functional significance in 
disease. A number o f other cell-surface receptors have been shown to exist in a cleaved 
soluble form in body fluids, but in only a few cases has a functional role been defined. In 
vitro, the soluble form o f ICAM-I has been shown to modulate ICAM-I mediated cell-cell 
interactions (Becker et al., 1991), and release of ICAM-I in the upper respiratory tract may 
inhibit rhinovims infection (Marlin et a i,  1990). The release o f cICAM-1 and other 
vascular adhesion molecules may be important in cell-signalling, chemo-attraction or 
adhesion blocking (Gearing & Newman, 1993). Soluble ICAM-I, at concentrations lower 
than we have detected in the plasma of children with malaria, has been shown to inhibit 
PRBC binding to ICAM-1 in an in vitro binding assay (Ockenhouse et a i ,  1992b), raising 
the possibility that the high level of cICAM-1 in malaria competitively modulates PRBC 
binding to endothelium in vivo.
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V I
C-reactive protein and haptoglobin in the evaluation of 
a community based malaria control programme
'McGuire, W., ^D'Alessandro, U., ^Olaleye, B.O., ^Thomson, M.C., 
^Langerock, P., ^Greenwood, B.M. & 'Kwiatkowski, D. (1996). 
Transactions o f  the Roya! Society o f  Tropical Medicine and Hygiene, 90, 10-14.
^Department o f  Paediatrics, Institute o f  Molecular Medicine, 
John Radcliffe Hospital, Oxford, UK,
^Medical Research Council Laboratories, Fajara, The Gambia
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Summary
When cross-sectional suiweys are used to evaluate malaria intervention programmes in the 
community, the prevalence o f morbidity is difficult to assess because o f the fluctuating 
nature o f malarial fever. We have therefore investigated the impact o f bed net usage on two 
surrogate markers of malarial morbidity: (i) elevated C-reactive protein (CRP) (>8mg/l) 
plus detectable parasitaemia, as an indicator o f malaria-induced acute-phase response; and 
(ii) reduced haptoglobin levels (<180mg/l) which in this population indicates malaria- 
induced intravascular haemolysis. Among 1505 Gambian children o f 1-5 years old, 
examined on a single occasion at the end o f the malarial transmission season, 5% had 
parasitaemia plus fever, while 24% had parasitaemia plus elevated CRP, and 35% had low 
haptoglobin. The proportion o f children who had parasitaemia plus elevated CRP was 
significantly lower than in those who had slept under insecticide-treated bed nets compared 
to those who did not use a bed net (16% vs 34%, f<0.003), and the proportion with a low 
haptoglobin differed similarly (24% 49%, f<0.003). Use of an untreated bed net had a
weaker effect on both indices (22% had parasitaemia plus elevated CRP, 34% had low 
haptoglobin). CRP and haptoglobin are simple and inexpensive to measure in large numbers 
of people, and these results suggest that they could be useful for the assessment o f malaria 
intei-vention programmes.
Introduction
It is important to evaluate the impact of malaria control strategies on the level of malaria- 
specific morbidity and mortality in the community. This is best determined by a period of 
longitudinal monitoring but, in rural African communities, this can be logistically complex 
and prohibitively costly. In general, estimates o f the level o f malaria morbidity rely on cross- 
sectional surveys o f a sample of the population. In endemic regions, however, malaria 
illness is not indicated solely by the presence of parasitaemia as many Plasmodium  
falciparum  infections, even at high density, are asymptomatic (Marsh, 1992). Disease 
episodes can be defined as parasitaemia associated with fever, and this case definition is 
appropriate for use in longitudinal studies (Snow el al., 1989). However, since malaria 
fever is typically intermittent, this definition of malaria illness is inappropriate for use in
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cross-sectional suiweys as disease episodes will be under-detected. The other traditional 
malariometric indices, spleen rate (the proportion with a palpably enlarged spleen) and 
prevalence of anaemia, are also of limited value as cross-sectional measures since they 
change only slowly in response to effective malaria control (Rougemont ef a/., 1988).
An awareness o f the limitations o f the standard malariometric indices has led to the 
suggestion that stable biochemical markers o f disease activity may be better cross-sectional 
measures o f the level o f malaria illness in a community (Rougemont ef. al., 1988; Sisay e( 
a!., 1992; Hurt et al., 1994). The main requirement of such a marker is that it reflects 
disease activity rather than simply parasitaemia.
A potentially useful marker of disease activity is C-reactive protein (CRP). This is an acute 
phase protein, generated in response to pyrogenic cytokines (TNF, interleukins 1 and 6) 
which host monocytes and macrophages secrete when malaria schizonts rupture 
(Kwiatkowski et al., 1989; Karunaweera et al., 1992). These cytokines have a short half- 
life in plasma and therefore, like fever, are not usefiil as cross-sectional epidemiological 
markers. Several studies have demonstrated increased plasma CRP levels in African 
children with malaria (Ree, 1971; Naik & Voiler, 1984; Hurt et al., 1994). When malaria 
fever has remitted in patients treated for falciparum malaria plasma CRP remains elevated 
for several days (unpublished observation). CRP may therefore be a more stable marker of 
disease activity than is fever. In the same way that elevated body temperature associated 
with parasitaemia defines a clinical malaria episode in longitudinal surveys, an elevated 
plasma CRP level associated with parasitaemia may be a better index o f malaria illness, for 
use in cross-sectional surveys, than is parasitaemia alone.
Another possible marker is haptoglobin. Although this is an acute phase protein, its 
expression is not increased to the same extent as is CRP in response to pyrogenic cytokines 
(Stadnyk & Gauldie, 1991), and the principal effect of malaria parasitaemia on haptoglobin 
relates to intravascular haemolysis. Haptoglobin binds and clears free haemoglobin and 
therefore haemolysis results in reduced plasma haptoglobin levels. Haemolysis secondary to 
malaria is the only significant cause of hypohaptoglobinaemia in African populations (Trape 
et al., 1985). It has been proposed that the distribution o f haptoglobin levels may be useful
in the evaluation o f malaria control programmes (Rougemont et a!., 1988; Trape & 
Fribourg-Blanc, 1988; Sisay e / «/., 1992).
The aim of this study was to investigate the usefulness of CRP and haptoglobin as surrogate 
markers of malaria morbidity and to define their relationship to conventional malariometric 
indices. Our strategy was to determine how CRP and haptoglobin levels were affected by 
bed net usage which, in several studies in The Gambia, has been shown to reduce malaria 
morbidity and mortality (Snow e/ur/., 1988a, 1988b; Alonso c /a /., 1991 ; D'AIessandro c/ 
a!., 1995a, 1995c).
Subjects and Methods
In June 1992, the Gambian government implemented a national impregnated bed net 
programme (NIBP) in about half of all the primary health care (PHC) villages in the 
country. The aim was to treat all of the bed nets in the selected villages with the insecticide 
permethrin. PHC villages usually have a population of greater than 400 and support a 
resident village health worker and traditional birth attendant. During the subsequent 
transmission season (August-December 1992) the Medical Research Council longitudinally 
monitored the impact o f the programme on malaria mortality (See D'Alessandro et al.,
1995a for details).
In addition to the longitudinal assessment, a cross-sectional clinical survey of a sample o f 
the population was undertaken at the end o f the 1992 rainy season (October and 
November). During this survey, we randomly selected 1505 Gambian children (aged 1-4 
years) from villages from each of the 5 NIBP sui’veillance areas (the areas are described by 
Thomson et al., 1994 and D'Alessandro et al., 1995a). The children were examined, their 
axillary temperature measured and spleen size estimated, and a finger-prick blood sample 
was taken for parasitological examination, PCV measurement and CRP and haptoglobin 
assay. The blood was collected into a tube containing sodium ethylenediaminetetraacetate 
( 1 mg/ml) and aprotinin (0.5 tiypsin inhibitor unit/ml) and plasma was separated immediately 
by centrifugation at 10000 g  and stored frozen until assayed. Further details of the cross- 
sectional suiwey are given by D'Alessandro et al. (1995c).
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CRP deterniination
Plasma CRP was determined by ELISA, based on the method o f Voiler et al. (1980). 
Briefly, microtitre plates were coated with rabbit anti-human CRP polyclonal antibody 
(Dako) in Tris-HCl. After washing, samples diluted 1:10000 in phosphate buffered saline 
and CRP standards (Dako) in the range 0.8 to 50mg/l were added and the plates incubated 
at 37°C for 2 hours. After washing, a horse-radish peroxidase (HRP) conjugated anti-CRP 
antibody (Dako) was added and after 2 hours incubation at 37''C the plates were washed 
again before o-phenylenediamine dihydrochloride (QPD) (Sigma) in phosphate-citrate 
buffer was added. The reaction was stopped with sulphuric acid and the optical density at 
492nm measured. Under these conditions, the lower limit o f detection was 7.8 mg/1 and, for 
statistical purposes, results below this were assigned values o f 5mg/1.
Haptoglobin defennination
Plasma haptoglobin was also determined by ELISA, based on the method described by 
Yerly et al. (1990). Briefly, microtitre plates were coated with sheep anti-haptoglobin 
polyclonal antibody (Serotec) in borate buffered saline (BBS). After washing, samples 
diluted 1:20000 in BBS and standards (Sigma) in the range 0.8 to 50ug/l were added and 
incubated at 37”C for 2 hours. After washing, an HRP conjugated anti-haptoglobin antibody 
(Serotec) was added and after 2 hours the plates were washed again before OPD in 
phosphate-citrate buffer was added. The reaction was stopped with sulphuric acid and the 
optical density at 492nm measured. Under these conditions, the lower limit of detection was 
7.8mg/I and results below this were assigned values of 5mg/1.
Statistical analysis
Two separate comparisons were made: (i) children who did not sleep under bed nets were 
compared to children who slept under untreated bed nets, and (ii) children who did not use 
bed nets were compared to children who used insecticide treated nets. This second 
comparison only included children who lived in PHC villages since insecticide treatment of 
bed nets was only available in PHC villages. In making comparisons, additional confounding 
variables were accounted for by stratifying in a Mantel-Haenszel test.
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U hical approval
All aspects of the study were approved by the Gambia Government / MRC Joint Ethical 
Committee. Prior consent was obtained from the guardians o f all children included.
Results
In all, 1505 children, 50% female, were studied. Mandinka was the most common ethnic 
group (33%), followed by Fula (20%), Sarahuli (19%), Jola (15%), and Wollof (10%). 770 
(51%) children slept regularly under an untreated bed net and 350 (23%) a permethrin 
treated net, and 385 (26%) did not use a bed net.
Clinical profile afid standard malariometric indices
Asexual forms of P.falciparum  were detected in 570 (38%) children. O f these, 79 ( 14%) 
were febrile with an axillary temperature >37.5"C. In 210 (37%) o f the parasitaemic 
children the parasite density was >5000/ul, and amongst those, 51 (24%) were febrile.
In total, fever was detected in 95 (6.3%) children. Of these febrile children, 79 (83%) had 
detectable/7/67/c7/2£7/7/w parasitaemia and 51 (54%) had parasitaemia >5000/ul. A palpably 
enlarged spleen (Hackett class >0) was detected in 330 (22%) children; 157 (10%) children 
had significant anaemia (PCV <25%).
The effect of untreated and treated bed net use on these standard malariometric indices has 
been presented in detail elsewhere (D’Alessandro et al., 1995c) and is summarised in Table 
10.
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Table 10. Summary o f effect of bed net use on standard malariometric indices in the 
population sample for whom plasma levels of C-reactive protein and haptoglobin were 
available.
All villages PHC villages only
No bed net Untreated No bed net Treated
bed net bed net
n= 385 770 215 348
Parasite rate 52% 35% 51% 28%
Parasitaemia
>5000/ul
19% 14% 17% 9%
Spleen rate 31% 21% 28% 16%
Mean PCV 
(SD)
31,4
(4.9)
32.1
(4.8)
31.9
(4.9)
33.0
(4.4)
DistrihuHon o f  CRP and haptoglobin within the sample
An elevated CRP, defined as >8 mg/1 (Young et a i ,  1991), was detected in 37% of the 
sample. High CRP associated with P. faiciparum  parasitaemia was found in 24%. High CRP 
associated with P. faicipatiim  parasitaemia >5000/ul was detected in 11%.
Plasma CRP levels in this sample were unrelated to sex, age or ethnic group but varied, as 
did the standard indices such as parasite and spleen rates, between the 5 NIBP surveillance 
areas. The proportion o f children with an elevated CRP was highest in the eastern part of 
the country in surveillance areas areas 4 and 5 (49% in areas 4-5 compared to 30% in areas 
1-3, V  = 52, / '< 0 .0 0 1 ) .
A low level o f haptoglobin (<180mg/l; Rougemont et al., 1988; Yerly et a i,  1990) was 
found in 35% of the children. As with CRP, plasma haptoglobin levels varied between 
NIBP surveillance areas. The proportion o f children with a low haptoglobin was highest in 
the two surveillance areas in the east o f the country (46% in areas 4-5 compared to 27% in 
areas 1-3, Mantel-Haenszel (stratified for age) ^115 , jP<0.001). Haptoglobin levels 
were inversely related to age (allowing for area) but unrelated to sex or ethnic group.
Relationship o f  CRP and haptoglobin to parasitaemia and fever  
CRP levels were higher, in parasitaemic than in non-parasitaemic children ( f  <0.001 by 
Mann-Whitney U test) and CRP and parasite density were correlated in the 570 
parasitaemic individuals (Spearman correlation co-efficient (all values log transformed) =
0.4, P<0.001) (Table 11, Fig. 5).
Higher plasma CRP levels were also associated with the presence o f fever (F<0.00! by 
Mann-Whitney U test) and the proportion o f children with an elevated CRP was higher in 
the febrile compared to afebrile groups (81% versus 34%: Mantel-Haenszel X^ (stratified 
for parasite density above and below 5000/ul) = 18.7, P<0.001).
Haptoglobin levels also differed significantly between the parasitaemic and aparasitaemic 
groups (7^<0.001 by Mann-Whitney U test) but haptoglobin levels did not differ between 
those with a parasitaemia >5000/ul and those with lower parasite densities (Fig. 6). -i
Similarly, whereas parasite density in infected individuals correlated with CRP, there was no }
correlation between parasite density and haptoglobin level. Haptoglobin levels do not differ 
significantly between the febrile and afebrile groups (allowing for parasitaemia and age).
Relationship o f  CRP and haptoglobin to other clinical indices
An elevated CRP level (>8mg/l) was significantly associated with the presence o f palpable 
splenomegaly (Mantel-Haenszel (stratified for parasitaemia) = 19.4, P<0.001) and o f 
anaemia {X^ == 12.0, F<0.001) (Table 11). Hypohaptoglobinaemia (<180mg/l) was 
associated with splenomegaly (Mantel-Haenszel X^ (stratified for age and parasitaemia), = 
43.5, p<0.001) and anaemia {X^ ~ 9.5, P<0.003).
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Fig. 5. Frequency distribution o f  plasma C-reactive protein levels stratified for density o f  
parasitaemia; open bars, <8mg/l; hatched bars, <50m g/l,, solid bars, >50mg/l
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Fig. 6. Frequency distribution o f  plasma haptoglobin levels stratified for density o f  
parasitaemia: open bars, < l80m g/l, hatched bars, <1000m g/l,, solid bars, > I OOOmg/l
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Effect o f  bed net use on CRP and haptoglobin levels
Data for children who did not sleep under a bed net and those who used either a treated or 
an untreated net are compared in Table 12. To determine if the observed differences in rates 
o f raised CRP and low haptoglobin were due to the effect o f bed net use, we allowed for 
confounding variables and calculated weighted Mantel-Haenszel odds ratios.
A significantly smaller proportion o f the group o f children who slept under insecticide- 
treated bed nets had an elevated CRP associated with parasitaemia than did those who did 
not use a bed net (Mantel-Haenszel (allowing for both area and age) = 8.9, P=0.003; 
odds ratio = 0.49, 95% confidence limits (Cl) 0.3-0.79). Elevated CRP plus parasitaemia 
>5000/ul was less common in children using treated bed nets than in those not using them, 
but the difference was not statistically significant. Use o f a treated bed net, compared to no 
net, was associated with a reduction in the proportion o f children with a low haptoglobin 
(Mantel-Haenszel X^ (allowing for both area and age) = 8.5, P=0.003; odds ratio = 0.53, 
95% Cl 0.34-0.81). When use of untreated bed nets was compared with no net use, there 
was a similar trend to that obseiwed with treated bed nets for all o f the indices examined, 
but the trends were not statistically significant.
Table 12. Effect o f bed net use on plasma levels o f C-reactive protein and haptoglobin.
All villages PHC villages only
No bed net Untreated No bed net Untreated 
bed net bed net
n= 385 770 215 348
High CRP
Any parasitaemia 35%
Parasitaemia >5000/ul 16%
22%
11%
34%
15%
16%
7%
Low haptoglobin 45% 34% 49% 24%
65
D iscussion
In this sample of 1505 rural Gambian children, surveyed during the malaria transmission 
season, 3 8% had detectable P. faiciparum  parasitaemia but, o f these, 86% were apyrexial 
when examined. Even in the group of children with parasite densities >5000/ul, the 
estimated threshold for fever in The Gambia (Greenwood et al., 1987), 76% were apyrexial 
when examined. It is likely that a proportion o f the afebrile parasitaemic children were 
febrile in the previous days and/or would have become febrile subsequently. We, and others 
(Trape el al., 1985), have observed afebrile parasitaemic children who have subsequently 
become febrile within hours o f the original examination. As a consequence o f the 
intermittent nature o f malaria fever, the usual clinical case-definition o f malaria (elevated 
body temperature associated with parasitaemia, in the absence o f another cause o f fever), 
while appropriate for frequent longitudinal sui-veillance (Snow et al., 1989), is less useful as 
a cross-sectional morbidity index. Several workers have therefore suggested that alternative 
cross-sectional malariometric indices should be considered and evaluated (Rougemont ef 
al., 1988; Marsh, 1992; H m te ta l . ,  1994),
Both CRP and haptoglobin have been proposed as surrogate measures of malaria morbidity 
for use both at the individual and the population level (Rougemont et al., 1988; Trape & 
Fribourg-Blanc, 1988; Gillespie c /a /., 1991; Sisay c /a /., 1992; Hurt c/r/A, 1994). We 
wished to assess these proteins, not to improve diagnostic precision at the individual level 
but as surrogate markers of malaria morbidity in the community.
A plasma CRP level >8mg/1 was found in 37% of the children. CRP levels were more 
elevated in parasitaemic than in aparasitaemic children and parasite density and CRP level 
were significantly correlated. Given this correlation, we postulate that malaria is a 
predominant reason for increased CRP in this population. Elevated CRP was also found in 
21% of the aparasitaemic children (Fig. X). Some of these cases may have been due to 
cleared or sub-patent parasitaemia, since in Gambian children undergoing treated we have 
noted that plasma CRP levels may remain elevated beyond the time when parasitaemia has 
been cleared (unpublished observation). However, as infections other than malaria will have 
accounted for a proportion o f the cases of elevated CRP, we coupled the measurement with
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parasitaemia to increase the malaria specificity of the index. The proportion of children with 
an elevated CRP associated with patent parasitaemia was lower in the group who slept 
under insecticide treated bed nets compared to those without nets. A similar trend was seen 
with untreated bed net use, but this was not statistically significant. No direct estimate o f 
specificity or sensitivity can be made from this approach, since we have no 'gold standard' 
cross-sectional definition o f malaria illness, but these findings reflect the impact of bed net 
use on malaria morbidity (monitored longitudinally) and mortality (Snow et a i,  1988b; 
Alonso et al., 1993; D'Alessandro et al., 1995a).
In hyperendemic regions, where up to 90% of children may be parasitaemic at a given time, 
a problem with this definition (elevated CRP associated with patent parasitaemia) may be 
low specificity. If the index is defined as elevated CRP combined with high parasitaemia 
then disease specificity may be improved with little loss of sensitivity (Hurt et al., 1994).
We used a cut-off level of 5000 parasites/ul as this has previously been defined as the 
threshold for fever in The Gambia (Greenwood et al., 1987). In other epidemiological 
settings, calculation o f the fraction of fever cases attributable to malaria at each level of 
parasite density has been used in the choice of a cut-off value. (Armstrong Schellenberg et 
al., 1994; Smith et a i,  1994). However, only 11% of our total study population were found 
to have an elevated CRP associated with parasite density >5000/ul and therefore the 
analysis was performed on a smaller sample size than for the other indices examined. 
Although there was a clear trend, when confounding variables were allowed for, bed net 
use was not found to significantly affect the proportion of children with this definition.
Intra-vascLilar haemolysis secondary to malaria is the only significant cause of 
hypohaptoglobinaemia in African populations (Trape et al., 1985). It is therefore 
unnecessary to combine a reduced haptoglobin level with the detection of parasitaemia in 
order to make the index more malaria specific. Although significantly lower in the 
parasitaemic compared to the aparasitaemic group o f children, levels o f haptoglobin (unlike 
CRP) levels are not correlated with parasite densities in infected individuals. This may imply 
that even a low degree of parasitaemia is sufficient to cause a significant reduction in 
plasma haptoglobin but could also be a reflection of the delay in return of haptoglobin levels 
to the normal range following a reduction in parasitaemia.
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Bed net use was found to be associated with a decrease in the prevalence of 
hypohaptoglobinaemia, reflecting the effect of bed net use on malaria morbidity and 
confirming the finding o f a previous study in The Gambia (Sisay el al., 1992). Therefore, 
although the plasma haptoglobin level may not be useful in the diagnosis o f disease episodes 
at the individual level, we found, as have others, that it may be useful as a surrogate index 
of endemicity at the community level (Trape et al., 1985; Rougemont et a i ,  1988; Hurt, 
1994).
CRP and haptoglobin levels varied between the NIBP surveillance areas, reflecting different 
ecological and cultural differences in The Gambia. The proportion o f children with an 
elevated CRP or low haptoglobin was significantly higher in the eastern part o f the country 
than further west. This agrees with a baseline survey undertaken in 1991, in which the levels 
o f malaria parasitaemia and splenomegaly were found to be highest in villages situated in 
the eastern areas 4 and 5 (Thomson el al., 1994). Biochemical markers such as these could 
be developed as surrogate measures of relative malaria endemicity in different geographical 
regions. Since the measurement o f CRP and haptoglobin by ELISA is simple and 
inexpensive, determination of their levels could also be considered as complementary or 
alternative means far the initial assessment o f community -based intervention programmes, 
especially if cross-sectional, rather than longitudinal, surveillance is planned.
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VII
Concluding Discussion
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The host inflammatory response is a critical arm o f  innate immunity but may contribute to 
the pathogenic processes leading to severe malaria. In investigating the contribution o f 
complex cytokine cascades to pathogenesis, the problem is to distinguish molecular 
mechanisms that are causal from those that are epiphenomena o f  the disease process. One 
o f  the strongest pieces o f evidence for the pathological relevance o f  a putative molecular 
mechanism is to demonstrate that functional polymorphisms o f the corresponding genes 
affect clinical outcome. The association o f a genetic variant with the clinical outcom e o f 
disease strongly argues for the product o f  that gene, or o f a closely linked gene, being involved 
in the pathological process (Lander & Schork, 1994). We have used this genetic approach to 
investigate the role o f  TNF in the development o f  severe malaria.
We have found the TNF promoter variant TNF .3 0 8  A (TNF2) to be associated with cerebral 
malaria in the Gambian case-control study o f  severe malaria and hypothesised that this 
association may be due to increased TNF production (Chapter II). Early evidence suggested that 
the TN F .308 A allele affected TNF production (Wilson e t  a l ,  1994). Since this observation was 
made, several groups have further examined the functional aspects o f the TN F .308 A allele at the 
cellular level. Increased TNF production is associated with TNF -308 A in some studies (Bouma 
e l  a i ,  1996; Kroeger e t  a i ,  1997; Wilson e t  a i ,  1997), but not all (Brinkman e t  a l . ,  1996;
Stuber e t  a i ,  1996). A number o f groups have described associations with the TNF .308 A 
allele with other infectious diseases. These include leishmaniasis (Carbera e t  a i ,  1995), 
meningococcal septicaemia (Nadel e t  a i ,  1996), trachoma (Conway e t  a i ,  1997) and 
leprosy (Roy e t  a i ,  1997).
With regard to the TNF .238 A allele, found to be associated with severe malarial anaemia 
(Chapter 111), there are few data on its functional importance. Only one study has been 
published and this failed to demonstrate an effect on TNF response to short term 
stimulation with bacterial Hpopolysaccharide (Pociot e t  a l . ,  1995). However, it is unclear 
whether TNF production following chronic stimulation o f macrophages or monocytes by P .  
f a l c i p a r u m  would be affected by the TNF .238 A allele; further studies are required.
We recognise that the disease associations that we have described may be due to the 
existence o f other alleles in linkage disequilibrium with the TNF prom oter alleles, either in
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TNF or in a neighbouring gene. Although we have demonstrated both associations to be 
independent o f variation in the HLA-class I and class II region, the MHC, including the 
HLA-class III region, may contain up to 200 immunologically relevant genes. Additionally, 
the flinctional importance o f more recently defined point polymorphisms in the TNF 
promoter has yet to be investigated (Hamann et al., 1995; Zimmerman et al., 1996).
The importance of the associations that we have described in a Gambian population may be 
investigated by determining if the same associations also exist in a genetically diverse 
population (in East Africa, for example). However, undertaking further large case-control 
studies in rural Africa is logistically difficult. A major problem in many populations is ethnic 
admixture; a confounding variable for genetic association studies (Lander & Schork, 1994). 
Fortunately, the Gambian population consists o f several veiy clearly defined ethnic sub­
groups and population stratification could be accounted for when the associations were 
analysed. An alternative approach, wliich obviates the confounding effect o f ethnic admixture, is 
family-based association studies where the parental alleles not inherited by the cases serve 
as the control ‘group’. This strategy may be more applicable than traditional case-control 
studies to the future investigation o f genetic associations with malaria in African children 
(Hill, 1997).
The genetic approach may be applied to the investigation of the putative role o f several 
other host inflammatory mediators in the pathogenesis of malaria. We have discussed the 
difficulty o f defining the pathogenic importance o f the soluble TNF receptors and o f the 
endothelial receptor, ICAM-1, by analysing plasma levels o f the proteins (Chapters IV and 
V). Recently, Kurtzhals et aL  (1998) have measured plasma levels of TNF and interleukin- 
10 in African children with malaria and suggested that severe malarial anaemia is related to 
an insufficient counter-inflammatoiy response (IL-10) to high TNF concentrations.
Similarly, there is controversy regarding the role of nitric oxide in the pathogenesis o f 
severe malaria; the currently available clinical data give conflicting findings based on 
measurement of plasma reactive nitrogen intermediates (Al Yaman et a l ,  1996; Anstey et 
al., 1996; Kremsner et al., 1996). Supportive evidence for the involvement of these 
mediators in the pathogenesis o f malaria may be sought via association studies using 
polymorphic markers in the genes coding for these molecules. For example, a recent study
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in Kenya demonstrated an association o f a high frequency polymorphism in the binding 
domain of ICAM-1 with susceptibility to cerebral malaria thus implicating this molecule in 
the pathogenic process (Fernandez-Reyes et al., 1997). However, it should be stressed that 
although this approach has great potential, caution should be exercised in the interpretation 
o f associations defined. In addition to the issue o f population stratification in case-control 
studies discussed above, it is important to recognise that increased efficiency in molecular 
biology techniques could result in multiple-hypothesis testing, aggravated by publication 
bias o f positive associations. Statistical correction for multiple testing is essential before 
commenting on the significance o f genetic associations.
In addition to the candidate gene approach discussed above, advances in automated 
molecular techniques to characterise polymorphic microsatellite markers and computer 
software to construct high resolution genetic maps will allow genetic linkage studies 
covering the entire genome to be undertaken. Whereas the candidate gene approach 
requires a prior hypothesis for the involvement o f a given mediator in pathogenesis, the 
whole genome approach can lead to the identification of new major susceptibility genes 
which may allow novel pathological pathways to be uncovered. Marquet el al. (1996) have 
used this approach to identify a gene in a region on the short arm o f chromosome 5 that 
governs intensity o f infection to Schistosoma mansoni. Intriguingly this region encodes IL- 
4, IL-5 and several other immunological mediators. In the case o f malaria, it may be that in 
addition to those genes recognised to be o f importance from association studies, other 
unidentified genes o f greater importance are yet to found.
The aim of exploring the molecular mechanisms involved in a complex disease such as 
severe malaria is to improve therapeutic or preventative strategies. In the case o f TNF, the 
trial o f anti-TNF monoclonal antibody therapy in cerebral malaria in Gambian children 
resulted in a disappointing outcome (Boele van Hensbroek et al., 1996). However, use of 
pentoxifylline, an inhibitor of TNF production, has been more promising and may merit 
further study (Di Perri et al., 1995). With regard to prevention, several groups have 
endeavoured to define the parasite moieties that induce the host inflammatory response in 
vivo as these may form the basis o f an ‘anti-disease’ malaria vaccine (Playfair et al., 1990). 
Current evidence suggests that the TNF-inducing factors contain an inositol-containing
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phospholipid, possibly glycosylphosphatidylinositol, but further molecular definition is 
required (Bate el a!,, 1992; Bate & Kwiatkowski, 1994; Schofield & Hackett, 1993; 
Schofield el al., 1996; Tachado el al., 1997). In addition, before the case for an anti-disease 
vaccine can be advanced, an improved understanding of the molecular basis and the 
epidemiological significance of the natural anti-toxic antibody response in malaria-endemic 
populations is required (Kwiatkowski et al., 1997).
In conclusion, the continued investigation o f the role of the host inflammatoi'y response in 
the complex pathogenesis of severe malaria in African children may ultimately lead to 
improvements in therapeutic or preventative strategies. This should continue in parallel with 
the on-going study of the many overlapping molecular processes involved in the course of 
malaria infection, such as the adhesion of parasitised erythrocytes to vascular endothelium 
(Newbold el a!., 1997). Crucially, such research should be regarded as complementary to 
the continued study o f the epidemiology o f severe malaria (Snow el al., 1997) and to the 
development o f Mow-technology’ community-based interventions such as use of insecticide- 
impregnated bed nets (D ’.Alessandro et a!., 1995a). A coordinated, multi-disciplinary effort 
in the laboratoiy and in the field is essential if the devastating consequences of malaria 
infection on the population o f sub-Saharan Africa are to be reduced.
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